WO1998058250A2 - Methods of calibrating and testing a sensor for in vivo measurement of an analyte and devices for use in such methods - Google Patents
Methods of calibrating and testing a sensor for in vivo measurement of an analyte and devices for use in such methods Download PDFInfo
- Publication number
- WO1998058250A2 WO1998058250A2 PCT/IE1998/000045 IE9800045W WO9858250A2 WO 1998058250 A2 WO1998058250 A2 WO 1998058250A2 IE 9800045 W IE9800045 W IE 9800045W WO 9858250 A2 WO9858250 A2 WO 9858250A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- sensor
- analyte
- signal
- measured
- subject
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/001—Enzyme electrodes
- C12Q1/005—Enzyme electrodes involving specific analytes or enzymes
- C12Q1/006—Enzyme electrodes involving specific analytes or enzymes for glucose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/1486—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using enzyme electrodes, e.g. with immobilised oxidase
- A61B5/14865—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using enzyme electrodes, e.g. with immobilised oxidase invasive, e.g. introduced into the body by a catheter or needle or using implanted sensors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/1495—Calibrating or testing of in-vivo probes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
- A61B5/6846—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive
- A61B5/6847—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive mounted on an invasive device
- A61B5/6848—Needles
Definitions
- This invention relates to devices and methods for measuring an analyte in vivo, and in particular to sensors for use in such devices and methods.
- WO 96/14026 describes an analyte-controlled liquid delivery device and analyte monitor in which an analyte such as glucose is detected by a platinum-iridium sensor needle having an enzymatic coating such as glucose oxidase.
- the sensor needle is typically located on a housing having a lower surface for application to the skin of a subject.
- Glucose in the presence of the enzymatic coating undergoes a reaction with oxygen, and one of the by-products of the reaction is hydrogen peroxide. This in turn is broken down by the platinum in the sensor needle which forms an electrode of an electrical circuit.
- the level of concentration of glucose is proportional to the magnitude of the current.
- the magnitude of the current through the electrical circuit can be used to determine the concentration of glucose.
- One method of calibrating such sensors is to use them to measure a standard solution of the analyte for which they are intended, and thereby determining the signal strength achieved from a known concentration of analyte.
- a calibration function which can in theory be used to derive the analyte concentration in vivo from the measured signal.
- the performance of a sensor may vary over the shelf life of the sensor. Additionally, when the sensor is actually used, it is in a different environment from that in which the batch was calibrated. The sensor will form part of a system in use which is partly biological and which will vary between individual subjects. For example, the laboratory batch calibration function may not take account of the presence of unwanted substances in vivo which give a false background signal.
- enzymatic sensors are subject to a deterioration in performance. This can happen as a result of the enzymatic material being physically or chemically degraded, or as a result of a build up of biological material on the sensor, for example.
- WO 96/14026 incorporated herein by reference, a method of detecting a decrease in the performance level of a sensor is disclosed. In this method, a pulsatile sampling technique is used in which pulses of current are detected at or about a peak value and at or about a base line value.
- the ratio of the two measured currents was found to be independent of the concentration of the analyte being measured, such that if this ratio was found to change over time, one could deduce that the performance of the sensor had changed in some way (usually due to degradation).
- the present invention seeks to provide an alternative and more reliable method of monitoring sensor performance and degradation.
- the present invention seeks to provide an alternative method of testing a sensor to detect changes in the sensor performance.
- the invention provides a method of calibrating an analyte sensor in vivo, comprising the steps of:
- the method according to the invention provides a way of using the response attained from a predetermined stimulus to evaluate the response to subsequent stimuli, i.e. actual measurements recorded by the sensor in vivo, taking into account the condition of the sensor and the conditions encountered in use.
- the first predetermined stimulus is generated by providing a supply of material to which the sensor is sensitive, such that the material stimulates the sensor when the sensor is applied to a subject.
- the material is provided in the vicinity of the sensor in a form in which it is soluble in biological fluids present in the area of the subject to which the sensor is applied.
- a soluble material will be released to the sensor upon application to the body, and since the speed of dissolution and the transport of dissolved material in the body can be accurately predicted, so can the time at which the material reaches the sensor and the concentration of material thereby encountered by the sensor.
- the material comprises an analyte or a precursor or derivative thereof.
- the sensor generates a reliable response to whichever material is chosen, but by choosing the analyte or a closely related substance as the relevant material, a relatively simple sensor which is only required to be sensitive to one substance or a small range of substances can be used.
- a salt of the analyte which exhibits a high solubility in vivo.
- the predetermined stimulus is adapted to saturate the sensor such that the first signal is a maximum signal.
- a sensor When a sensor is such that it can be saturated by a sufficiently large stimulus, it can be preferable to use this phenomenon in calibrating the sensor as it enables a reproducible first predetermined stimulus, i.e. a saturation stimulus to be provided in all cases, thereby removing uncertainty as to whether the means for providing a predetermined stimulus will in fact achieve exactly the right level of uncertainty.
- a reproducible first predetermined stimulus i.e. a saturation stimulus
- the method according to the invention further comprises the steps of providing a second predetermined stimulus to the sensor so as to produce a second sensor signal and measuring the second sensor signal, such that the determination of the calibration function is based on the first and second measured sensor signals.
- the second sensor signal is a base line signal measured when substantially no analyte is in the vicinity of the sensor.
- a base line signal in combination with a saturation signal is preferred as this enables the sensor to be calibrated for all useful signals, and these two endpoints can enable the sensor reaction to be extrapolated for intermediate points.
- the second predetermined stimulus is provided by consuming substantially all of the analyte in the vicinity of the sensor.
- the consumption of analyte in the vicinity of the needle causes the sensor to generate a base line signal which is attributable only to factors other than the presence of analyte (e.g. extraneous substances which generate false analyte measurements, residual background signals generated by the sensor, etc.).
- the analyte is measured by the sensor by means of an electrochemical reaction, with the sensor forming part of an electrical circuit, and the analyte is consumed by providing a current through the circuit which causes the analyte to undergo the electrochemical reaction, with the measurement of the second sensor signal being carried out shortly after the analyte is consumed.
- the advantage of this method of consuming analyte is that the apparatus required to consume the analyte can be the same apparatus which is present in any event as part of the sensor and associated components.
- the first and second signals constitute known points on a measured performance curve describing the measured performance of the sensor
- the calibration function correlates the measured performance curve with a theoretical sensor performance curve for which there is stored a calibrated output, such that any further sensor signal measurement from the sensor can be calibrated by correlating the point on the measured performance curve to which the measurement relates with a corresponding point on the theoretical sensor performance curve, and hence with the corresponding calibrated output.
- the theoretical sensor performance curve can be determined during the design of the sensor, can be measured for individual sensors during production, or can be measured for a manufactured batch of sensors on a statistical basis. Two curves having basic common parameters (such as a common shape) can thus be correlated to one another by comparing known points on each curve and extrapolating for subsequently measured points.
- the known points on a curve describing the measured performance of the sensor are endpoints of the curve. If the curve has a well defined shape, two endpoints may enable the intervening points to be calculated with accuracy. Indeed if one of the endpoints is always exactly zero (as in the case of a linear curve whose only variable is the slope), then a single saturation endpoint may describe the entire curve mathematically.
- a particularly preferred analyte is glucose.
- the advantages of having a reliable alternative method of measuring glucose in vivo are plain given the number of diabetics for whom blood sampling tests several times daily are a fact of life.
- the most common method of blood sampling currently in use is a procedure in which the skin must be punctured on every occasion.
- the use of a continuous monitoring system was hampered by calibration difficulties, and so the present invention provides a way of removing this difficulty.
- the invention thus provides also a method of measuring an analyte in vivo comprising the steps of applying a sensor to a subject, calibrating the sensor according to the invention, and providing a calibrated output of any further measurements made by the sensor based on the calibration function.
- the invention provides a device for the in vivo measurement of an analyte, comprising:
- an in vivo sensor for measuring the analyte and providing a signal in response to the measurement of the analyte;
- this device is adapted to carry out the calibration method discussed above, and therefore has many of the same advantages associated therewith. Further features of such a device are set out below, the advantages of which will in many cases also be apparent from the above discussion.
- the means for providing a first predetermined stimulus to the sensor comprises a supply of material associated with the sensor such when the sensor is applied to a subject, the sensor is sensitive to the material.
- the supply of material is associated with a permeable protective coating provided on the sensor.
- the supply of material is provided in an amount sufficient to saturate the sensor and thereby generate a maximum signal which can be used to calibrate the sensor.
- the senor comprises an element which is adapted to be inserted subcutaneously, intradermally, intravenously or by surgical implantation into the subject, and the supply of material is provided on the sensor in soluble form.
- the sensor can be provided in the form of a needle on a device which can be affixed to the skin painlessly and worn unobtrusively, such that the sensor penetrates the skin to a predetermined depth.
- Presently preferred devices of this type comprise a housing having a lower surface for application to the skin of a subject, the sensor being in the form of a needle extending from the housing such that the sensor penetrates the skin of the subject when the device is applied thereto.
- means are provided for generating a base line signal corresponding to the signal obtained when substantially no analyte is present in the vicinity of the needle, and the base line signal is used to calibrate the sensor.
- the means for generating a base line signal comprises a voltage generator which forms part of the electronic circuitry, and the base line signal is provided by passing a current in the vicinity of the needle which eliminates the analyte or a chemical substance used in the measurement of the analyte.
- the analyte to be detected by the device is glucose.
- the invention also provides a method for the in vivo testing of an analyte sensor which is provided to a subject as an electrode of an electrical circuit, comprising the steps of: (a) applying a potential to the electrode and varying the electrode potential so as to cause the electrode current to undergo at least part of a cycle which exhibits hysteresis;
- the shape of a hysteresis cycle for the electrode will change, and if a characteristic point on such a cycle has been identified when the sensor is operating correctly, deterioration of the sensor may be identified by a change in the current-voltage response at such a characteristic point.
- the characteristic point is a nodal point on the hysteresis curve, with the nodal point preferably defined as a voltage for which the current value is independent of the analyte concentration in the vicinity of the sensor when the sensor is operating correctly.
- steps (a)-(e) of the method of testing the sensor needle are repeated periodically. This allows the sensor to be repeatedly tested while in use, thereby monitoring the sensor for deviations from the expected performance.
- an initial iteration of steps (a)-(d) yields a value for the characteristic point which is stored for comparative subsequent use.
- the initial iteration is repeated a plurality of times shortly after the sensor has been applied to the subject, and a supply of the analyte to be measured is provided to the sensor in varying concentrations during the repetition of the iterations.
- the analyte is supplied on the sensor in such a manner that it is released upon application of the sensor to the subject, and wherein the varying concentrations of analyte are achieved by consuming the analyte in a reaction or allowing the analyte to diffuse within the body of the subject.
- the determination of a characteristic point can be carried out at the time that the sensor is being calibrated in vivo, since as described above the in vivo calibration may employ varying levels in analyte concentration at the sensor, and these varying analyte levels also enable the current-voltage response to be measured at different analyte levels as part of repeated hysteresis cycles.
- the method suitably comprises the further step of providing an indicator if it is determined that the sensor does not meet the predetermined condition.
- the indicator comprises an audible alarm.
- the invention provides a device for the in vivo measurement of an analyte, comprising: (a) an in vivo sensor for measuring the analyte and providing a signal in response to the measurement of the analyte;
- (f) means for comparing the characteristic point with a stored value and for determining from this comparison whether the sensor meets a predetermined condition.
- Such a device is adapted for use in the testing method according to the invention and the advantages of this testing method as set out above also apply in large part to the corresponding device, as well as to many of the preferred features set out below.
- the characteristic point is a nodal point on the hysteresis curve
- the nodal point is preferably defined as a voltage for which the current value on the hysteresis curve is independent of the analyte concentration in the vicinity of the sensor when the sensor is functioning correctly.
- the device preferably comprises a memory for storing the value of a characteristic point determined on an initial iteration of measurements of current values.
- a further preferred feature is means for providing an alarm if it is determined that the sensor does not meet the predetermined condition.
- the invention provides, in another aspect, a method for the in vivo measurement of an analyte, comprising:
- water is the chemical species present in the vicinity of the sensor which is electrolysed to provide oxygen.
- step (b) continues for a duration sufficient to generate oxygen in an excess stoichiometric ratio relative to the analyte being measured at the sensor.
- oxygen generating pulses can be interleaved with the measurement pulses to ensure that at all times a sufficient amount of oxygen is present.
- the invention also provides a device for the in vivo measurement of an analyte, comprising:
- any of the devices according to the invention there may suitably be provided means for delivering a substance to the subject in response to the measured analyte values.
- the device may comprise a pump containing insulin which may be pumped at a controllable rate in response to measured glucose levels.
- a pump containing insulin which may be pumped at a controllable rate in response to measured glucose levels.
- the principles of operation of such a pump will be known to the person skilled in the art. and suitable examples are disclosed in WO 96/14026. incorporated herein by reference.
- the substance is a medicament suitable to correct a condition in the patient for which the analyte is an indicating agent.
- the invention further provides a device for calibrating an analyte sensor in vivo, comprising:
- the means for providing the first predetermined stimulus comprises a supply of material to which the sensor is sensitive, such that the material stimulates the sensor when the sensor is applied to a subject.
- the material is soluble in biological fluids present in the area of the subject to which the sensor is applied.
- the material comprises an analyte or a precursor or derivative thereof.
- the predetermined stimulus is adapted to saturate the sensor such that the first signal is a maximum signal.
- the device further comprises means for providing a second predetermined stimulus to the sensor so as to produce a second sensor signal and means for measuring the second sensor signal, such that the means for determination of the calibration function determines a calibration function based on the first and second measured sensor signals.
- the second sensor signal is a base line signal measured when substantially no analyte is in the vicinity of the sensor.
- the second predetermined stimulus is provided by consuming substantially all of the analyte in the vicinity of the sensor.
- the first and second signals constitute known points on a measured performance curve describing the measured performance of the sensor
- the calibration function correlates the measured performance curve with a theoretical sensor performance curve for which there is stored a calibrated output, such that any further sensor signal measurement from the sensor can be calibrated by correlating the point on the measured performance curve to which the measurement relates with a corresponding point on the theoretical sensor performance curve, and hence with the corresponding calibrated output.
- the known points on a curve describing the measured performance of the sensor are endpoints of the curve.
- the invention also provides a device for measuring an analyte in vivo comprising means for applying a sensor to a subject, means for calibrating the sensor according to the method of the present invention, and means for providing a calibrated output of any further measurements made by the sensor based on the calibration function.
- Fig. 1 A is a schematic diagram of an analyte monitor device according to the invention.
- Fig. 1 B is a schematic diagram of a display unit adapted for use with the monitor device of Fig. 1A;
- Fig. 2 is a view of the underside of the monitor device of Fig. 1A;
- Fig. 3 is an enlarged elevation of the sensor needle of the monitor device of Fig. 1A;
- Figs. 4A-4C are graphical representations of in vivo glucose levels in the vicinity of the sensor needle immediately after the monitor device of Fig. 1A is applied to a subject, the measured electrode current during the same period, and the applied electrode voltage during the same period, respectively;
- Fig. 5 is a plot of electrode current versus analyte concentration for an analyte monitor device according to the invention in three different environments
- Fig. 6 is a plot of electrode current versus analyte concentration for an analyte monitor device according to the invention in two different environments;
- Fig. 7 is a graphical representation of applied electrode voltage and measured electrode current for an analyte monitor device according to the invention.
- Fig. 8 is a comparative plot of electrode current against glucose concentration illustrating the effect of generating oxygen in vivo using a method according to the invention
- Figs. 9 and 10 each show a series of current-voltage hysteresis cycles measured at a number of different glucose concentrations using a method according to the invention, together with a current-voltage hysteresis cycle for the same sensor after sensor deterioration;
- Fig. 1 1 is a plot of in vivo glucose concentration against time measured in tests carried out on a dog, comparing the results obtained using a device according to the invention as compared with standard reference tests;
- Fig. 12 is a sectional elevation of an embodiment of a device according to the invention before final assembly by the user;
- Fig. 13 is a sectional elevation of the device of Fig. 12 after final assembly
- Fig. 13A is an enlarged detail of the device of Fig. 13:
- Fig. 14 is an elevation of an alternative construction of sensor needle to that shown in Fig. 3 Modes for Carrying Out the Invention
- Fig. 1 A is a schematic illustration of an analyte monitor device for the in vivo measurement of an analyte according to the invention.
- Fig. IB is a schematic illustration of a display unit, associated with the monitor device of Fig. 1 A, for providing a visual output of the measured analyte levels.
- the monitor device of Fig. 1A indicated generally at 10, comprises a housing 1 1 separable into a first part 12 and a second part 13.
- the second part 13 of housing 11 has a lower surface 14 which is provided with a working electrode 15, a counter electrode 16 and a reference electrode 17.
- the device 10 is adhered to the skin of a subject by means of a conductive adhesive gel on the surfaces of counter electrode 16 and reference electrode 17.
- Working electrode 15 is a platinum-iridium enzymatic sensor in the form of a needle the detailed structure of which will be described in detail below.
- Counter electrode 16 and reference electrode 17 are each in the form of a silver/silver chloride surface makes good electrical contact with the subject's skin by means of the adhesive gel thereon.
- the electrodes 15,16,17 are connected to a microprocessor 18 via a voltage controller 19.
- Voltage controller 19 is adapted to supply constant voltages, pulsed voltages or varying voltages between the working electrode 15 and reference electrode 16. The voltage is controlled by the microprocessor 18, and both microprocessor 18 and voltage controller 19 are powered by a battery 20.
- a switch in the form of a push button 21 is used to stop or start the operation of the device, and an alarm 22 is provided to alert the user in the event of glucose levels being excessively high or low.
- the alarm 22 may also be used for a variety of other functions, such as to alert the user in the event of device malfunction or low battery levels, for example.
- the monitor device 10 of Fig. 1A communicates with the display unit of Fig. I B by means of a low power radio transmitter 23.
- the display unit of Fig. I B indicated generally at 24, is provided with a corresponding radio receiver 25, a visual LCD display 26, and a battery 27 to power the unit 24. Measured analyte levels from measuring device 10 can thus be transmitted to display unit 24.
- Fig. 2 shows a view of the underside of monitor 10.
- working electrode 15 i.e. the enzymatic sensor needle
- counter electrode 16 and reference electrode 17, respectively are represented by two approximately semi-circular cross hatched areas.
- the lower surface 14 is provided with a suitable adhesive to hold device 10 securely in place against the subject's skin.
- the enzymatic sensor needle 15 is shown in Fig. 3 in elevation.
- the platinum-iridium needle 15 has a plurality of apertures 28 which contain the enzyme glucose oxidase 29.
- the glucose oxidase enzyme 29 is thus recessed from the surface of the needle 15 in order to protect the enzyme 29 from being physically damaged, for example, when the needle 15 punctures the skin of a patient.
- a protective membrane 30 is provided on the surface of the needle 15, with an external coating of glucose 31 which is used for the purpose of calibrating the needle in vivo, as will be described below.
- Membrane 30 is glucose-permeable and oxygen-permeable, but it is more permeable to oxygen than to glucose. This selective permeability helps to ensure that oxygen is in excess of glucose for the purpose of ensuring that the rate of reaction is not limited by an insufficient oxygen supply. This problem is discussed in more detail below.
- Suitable membrane materials include polyurethane, Nafion ("Nafion" is a Trade Mark for a perflourinated ion-exchange membrane), cellulose materials or polysiloxanes.
- Fig. 3 two dimensions are shown, namely the length / of the needle 15 and the diameter d of the needle 15. Suitable dimensions are a needle length 26 of 5 mm and a needle diameter 27 of 0.3 mm, although it will be appreciated that a wide variety of dimensions can be employed as required.
- the basic principle of operation of the monitor device 10 is as follows.
- the monitor device 10 (comprising reusable first part 12, which includes the electronic controlling circuitry, and disposable second part 13, which includes the enzymatic sensor needle 15) is applied to a subject by removing a release liner (not shown) which protects adhesive lower surface 14 and sensor needle 15 before use. and then pressing lower surface 14 against the skin of a subject so that sensor needle 15 penetrates the skin of the subject and enters the subcutaneous region where it is in contact with subcutaneous tissue.
- the silver/silver chloride electrodes 16 and 17 lie in contact with the skin of the subject by means of their adhesive conductive coatings.
- the display unit 24 is worn on the wrist of the subject or is located in some other suitable location (such as by a bedside or in a nurse's station to allow monitoring by third parties of a patient's condition).
- glucose in the blood, plasma or serum present in the subcutaneous region diffuses through protective membrane 30 as do oxygen and water.
- the glucose (C 6 H 12 0 6 ), oxygen (0 2 ) and water (H 2 0) react in the presence of the glucose oxidase according to the reaction:
- the hydrogen peroxide produced at the surface of the platinum- iridium needle is oxidised (the platinum acts as a catalyst) according to the reaction:
- the hydrogen peroxide serves as a source of electrons which are free to act as charge carriers if a potential is applied between the working electrode (sensor needle) 15 and the counter electrode 16.
- the microprocessor 18 causes the voltage controller 19 to apply a voltage to the working electrode 15.
- the magnitude of the voltage is determined as a potential difference between the working electrode 15 and the reference electrode 17. However, no current flows between these two electrodes and instead the current flows through the counter electrode 16 (which is at the same potential as the reference electrode 17).
- the circuit is a potentiostat, and the skilled person will be aware that this means that an accurate voltage can be applied to the working electrode relative to the counter-electrode, independent of the resistance between the electrodes, which might be expected to vary in individual cases.
- the microprocessor 18 measures the current flowing through the circuit of which the working electrode 15 and the counter electrode 16 form a part thereof. Since this current can only flow if free charge carriers are present, the current provides a measure of the number of charge carrying species in the vicinity of the working electrode 15. The majority of the current arises from the free electrons which are generated by the breakdown of hydrogen peroxide at the platinum (or platinum-iridium) needle surface. As described in WO 96/14026, the voltage is only applied periodically between the working electrode 15 and the counter electrode 16. While the voltage between the working electrode and counter electrode is switched off, glucose reacts continuously with oxygen and water to generate increasing amounts of hydrogen peroxide at the sensor needle 15.
- the measured contribution of charge carriers which arise from the breakdown of hydrogen peroxide is maximised relative to other charge carriers which might be present in the tissue of the user.
- Such other charge carriers give rise to a background level of current which is essentially constant over short periods of time.
- the measured current is integrated by the microprocessor 18 to provide a measure of the total charge giving rise to the measured current: If Q represents the total charge of the combined charge carriers in a current flowing from 0 to t seconds, then:
- the batch of sensor needles of which sensor needle 15 forms a part thereof will have been calibrated in the factory. This is most usually achieved by taking a statistically representative sample of needles from a production batch, carrying out a laboratory calibration (using a standard glucose solution, for example) and applying the results of this calibration for all of the needles in the batch (presuming that the batch appears to be of acceptable quality.
- the calibration of this batch can be encoded on second part 13 of the monitor device 10.
- this is achieved by using a machine readable encoding system (such as a bar code or a simple chip containing the calibration parameters) which is automatically read by the microprocessor when the first part 12 and the second part 13 are connected together, or when start button 21 is actuated.
- the sensor needle may have undergone some changes during storage, and thus the calibration function determined during a laboratory test may not be entirely accurate when a needle is in use in vivo. More importantly, the interface between the needle and the surrounding body tissue will always give rise to at least slight variations between the performance of otherwise identical sensor needles because of differences between individuals and between individual application sites on the same individual.
- Figs. 4A-4C are three graphs illustrating: (Fig. 4A) the in vivo glucose level for an interval of time immediately after the sensor needle 15 has been applied to the body; (Fig. 4B) the measured electrode current over the same interval; and (Fig. 4C) the periodic voltage pulses (which are generated by the voltage controller 19 under the control of microprocessor 18) applied to the electrodes and which give rise to the measured current shown in Fig. 4B.
- the glucose level will be initially above level G,, the initial higher level is not shown as it is only the saturation level which can be measured by the sensor and which is of importance for the calibration method.
- Signal I is stored in the memory of the microprocessor 18 as a first sensor signal.
- a prolonged pulse V 9 is applied which consumes all of the charge carriers at the sensor needle 15 due to hydrogen peroxide breakdown, i.e. giving a current signal I 9 which drops from a measure of the equilibrium glucose level G 2 to a measure of the background charge carrier level G 3 which is due to extraneous influences.
- Signal I 9 is also recorded by the microprocessor for calibration purposes.
- Fig. 5 shows a plot of the characteristic performance curves of three different sensor needles from the same batch.
- the graph shows the signal measured in the case of each needle at different analyte concentrations:
- Curve 40 is the theoretical or laboratory-calibrated performance curve measured in the manufacturing facility for the batch of sensor needles. This curve is the mean calibration curve for the batch of needles, measured from tests carried out on a statistically valid sample.
- Curve 41 is the measured performance curve of a first sensor needle in vivo and curve 42 is the measured performance curve of a second sensor needle in vivo.
- the in vivo needle represented by curve 41 is calibrated as follows: shortly after it is applied to the subject, a maximum sensor signal 41a is measured as described above (I,). The amount of glucose provided on the sensor needle is sufficient to ensure that this signal will lie in the saturation region. As further described above, periodic pulses are then applied to the needle and this causes substantially all of the excess glucose in the vicinity of the needle to be consumed until the equilibrium glucose level G 2 is reached, following which a prolonged voltage pulse causes the glucose concentration to drop to a base line level (G 3 ). At this point the second sensor signal 41b is measured as described above (I 9 ).
- the microprocessor compares each of these signals 41a, 41b with the corresponding signals on the theoretical or laboratory-measured signal-concentration curve 40 i.e. signal 41a is compared with signal 40a and signal 41 b is compared with signal 40b.
- the calibration curve 41 for the in vivo sensor needle can be mapped onto the theoretical calibration curve 40 by mapping two known points on curve 41 to two known points on curve 40. In the case of both curves, the saturated signal value and the base line signal value has been measured, so a calibration function mapping any intermediate point from curve 41 onto curve 40 is easily derived.
- the calibration function involves increasing all signals by an amount corresponding to the constant vertical distance between curves 40 and 41.
- the microprocessor calculates the corresponding point 40c and provides, as an output which is transmitted to the display unit, the calibrated measurement corresponding to point 40c which can then be displayed in meaningful units.
- the same basic principles apply to the calibration of the individual sensor needle which has characteristic measured curve 42.
- the calibration function must take into account the fact that the difference between the saturation signals 40a, 42a is considerably less than the difference between the base line signals 40b, 42b.
- the microprocessor in order to map a measured point 42c onto the corresponding point 40c on theoretical curve 40, the microprocessor must apply a concentration-dependent calibration function in which the amount added to (or subtracted from) the measured signal 42c, when mapping this signal to point 40c, varies in accordance with the position of this point along curve 42c.
- the microprocessor may be programmed to sound an alarm to indicate that the sensor is apparently defective and should not be used.
- Fig. 6 shows an example of the results of the calibration process achieved in an experimental trial.
- a calibrated reference curve 45 obtained by calibration of the sensor needle in vitro
- end points 45a saturation
- 45b base line
- a measured curve 46 is extrapolated by measuring saturation and base line end points 46a, 46b, respectively. From these measurements it is determined that the measured (in vivo) curve lies a constant 0.03 mA below the reference (laboratory calibrated) curve.
- a subsequent measurement 46c of 0.38 mA can then be correlated to a value of 0.41 mA on the reference curve, which in turn corresponds to a glucose concentration of 4 mM (72 mg/dlit).
- glucose concentration is shown on a logarithmic scale in which each equal step along the scale represents a doubling of glucose concentration. For this reason, it can be seen that the calibration function is extremely important, since a reading of 0.38 mA would otherwise be interpreted (from the reference curve) as relating to a glucose concentration of only slightly more than 3 mM.
- the correct operation of the sensor presupposes that all of the glucose present in the vicinity of the glucose oxidase will react (at least up to the point where the sensor needle is saturated).
- the rate of reaction is, in theory, limited by the amount of glucose (and thus this reaction can be used to measure glucose).
- oxygen may become the limiting factor in the reaction, rather than glucose. The result of this is that the current level will provide an indication of the amount of oxygen rather than the amount of glucose.
- Fig. 7 A solution to this problem is illustrated in Fig. 7, in which the voltage is provided in two repeating series of pulses, namely a series of current measurement pulses 50 and a series of oxygen-generating pulses 51.
- the series of current measurement pulses 50 of 0.6 V is used to measure current resulting from the hydrogen peroxide breakdown.
- the microprocessor measures the resulting electrode current 53 when these 0.6 V pulses are applied, and integrates the measured current 53 over the duration of the pulse to obtain a measurement of the charge carriers involved in the current pulse.
- the number of charge carriers is primarily determined by the amount of hydrogen peroxide generated by the reaction of glucose with oxygen and water.
- Each current pulse 53 is shown with a shaded area 54 which represents the additional current obtained by allowing the hydrogen peroxide to build up using a pulsatile measurement mode.
- the blank area 55 below shaded area 54 corresponds to the steady state current which would be obtained if there was no pulsatile measurement but instead there was a steady state measuring voltage.
- the series of oxygen-generating pulses 51 of 1.3 V is provided such that each 1.3 V pulse 51 immediately follows after a current measurement pulse 50.
- These oxygen-generating pulses 51 of 1.3 V serve to generate oxygen by electrolytically breaking down water. This generates a sufficient amount of oxygen to ensure that oxygen is in excess of glucose in the vicinity of the sensor needle, and it therefore follows that glucose is the limiting factor in the measurement process, ensuring an accurate measurement of glucose.
- the voltage is switched off for a period 52 of time to allow the glucose to react with the oxygen in the presence of glucose oxidase and produce hydrogen peroxide.
- the hydrogen peroxide breaks down at the needle 15 and when the current is switched on there is a current surge (as shown in the top half of the graph) which falls away to a base line level.
- the time periods indicated in Fig. 7 are not shown to scale.
- Representative times for the current measurement pulses 50 are preferably 0.0 Is- 1.0s, most preferably approximately 0.1s; for the oxygen-generating pulses 51 the time is also preferably 0.0 Is- 1.0s, most preferably approximately 0.1s; and for the accumulation period 52 between the end of an oxygen-generating pulse 51 and the next current measurement pulse 50, the gap is preferably 0.05s- 10s, most preferably approximately 1.0s. These times are given for reference purposes only, and depending on the particular circumstances, times lying outside these ranges may be suitable.
- Fig. 8 shows the results of using a series of oxygen-generating pulse as described above.
- Curve 60 shows the average electrode current generated by a sensor such as sensor needle 15 at increasing glucose concentrations up to 16 mM.
- Curve 61 shows the current generated when an oxygen-generating pulse is included in the cycle. It can be seen that this causes a dramatic increase in the maximum level of current obtainable, as well as in the current range corresponding to the range of glucose concentrations illustrated. The advantage of having a larger current range is that a more accurate measurement of the glucose concentration becomes possible.
- the invention encompasses a method for the in vivo testing of an analyte sensor which is provided to a subject as an electrode of an electrical circuit.
- Fig. 9 illustrates how this method operates.
- Fig. 9 five current- voltage (I-V) characteristic curves are plotted.
- the curves show the current response to a cyclically varying voltage.
- the voltage is varied in each case through a cycle from 0.0 V to 0.58 V.
- each of the I-V characteristic curves 70-73 exhibits hysteresis, i.e. the current values for the increasing voltage part of the each I-V curve are different to the current values for the decreasing voltage part of each curve.
- the current measured at 0.4 V for the background level curve 73 has two different values.
- the current measured at 0.4 V is approximately -0.25 mA (denoted at 73a).
- the voltage has reached 0.58 V and is decreased down to 0 V, it again passes through the level of 0.4 V. but a different current is measured, namely +0.5 mA (denoted at 731>).
- the four measured I-V curves 70-73 intersect: at a voltage of 0.26 V on the increasing part of each of the curves 70-73 (nodal point denoted at 74), the measured current level is -0.4 mA for all concentrations of glucose; and at a voltage of 0.12 V on the decreasing part of each of the curves 70-73 (nodal point denoted at 75), the measured current level is +0.35 mA for all concentrations of glucose.
- Curve 76 is the I-V characteristic for the same needle after it has deteriorated somewhat.
- the most normal reason for needle deterioration in vivo is that the surface of the needle becomes coated with protein such as fibrin by the body. Any coating on the surface of the needle may adversely affect the reliability of the sensor needle, and so deterioration of the sensor needle used in the measurement of curves 70-73 has been simulated by the addition of a light coating of cellulose acetate.
- the needle is then reinserted into the subject and the cyclical I- V measurement is repeated to give curve 76.
- the microprocessor calculates a series of I-V curves 70-73 as the glucose level falls from the saturation level to the background level, and by comparing these curves, obtains and stores a value for one or more nodal points 74,75 at which the glucose level has no effect on the current- voltage response for a correctly functioning sensor.
- the microprocessor Periodically thereafter (e.g. every 30 minutes or every hour), the microprocessor repeats the cyclical electrode voltage variation, and measures the current response. The current values at the voltages where nodal points were previously measured are then compared to the expected values, and any significant deviation indicates a deterioration in the functioning of the microprocessor.
- the microprocessor may be programmed to sound an alarm if the measured current differs from the expected nodal point value by e.g. 10% or more. Thus, the user will be alerted in good time if the sensor needle requires replacement.
- Fig. 10 shows a repetition of the measurements illustrated in Fig. 9, with curves 80, 81, 82 and 83 being I-V curves measured as the glucose concentration drops from a saturation level to a base line level. Nodal points 84 and 85 are easily identifiable. However, in this case instead of applying a coating of cellulose acetate, a coating of polyvinyl pyrrolidone (PVP) was used, and the resulting I-V curve 86 is plotted.
- PVP polyvinyl pyrrolidone
- Fig. 1 1 shows measurement results achieved with a glucose monitor according to the invention when compared to a reference average.
- a glucose monitor according to the invention
- Open triangles indicate points at which glucose was delivered.
- the line joining the small diamonds shows the glucose concentration in mg/dlit and the line joining the large squares indicates the corresponding measurements made using electrodes according to the invention.
- the reference line (small diamonds) is obtained from an average of four conventional glucose measurement tests, namely two analyses conducted by independent veterinary or medical laboratories, and two commercially available glucose testing kits ("Medisense' " and "Elite”).
- the line denoting glucose monitors according to the invention was obtained from an average of three electrodes of the type illustrated in Fig. 3. It can be seen from these results that glucose monitors according to the invention closely mimic conventional methods of monitoring glucose levels.
- the reference line was obtained from the average of four tests using fresh whole blood samples from the cardiovascular system whereas the sensor according to the present invention was monitoring the glucose levels in subcutaneous tissue. Accordingly, while one expects to see an almost immediate increase in glucose levels in the intravenous system after glucose is administered intravenously, one expects to see a delay when the glucose measurement is made subcutaneously. Furthermore, one expects the sharp peaks and troughs measurable in blood samples to be smoothed out or averaged slightly in subcutaneous tissue because of the delay involved in blood diffusing into such tissue.
- Fig. 12 shows a schematic illustration of a needle deployment mechanism which can be used for an analyte monitor according to the invention.
- the embodiment of Fig. 12 is based on the embodiment discussed above in relation to Figs. 1 -3, and like parts are denoted by like reference numerals.
- the device 10 includes a first part 12 and a second part 13.
- Second part 13 has a lower surface 14 on which a reference electrode 16 and a counter electrode 17 are situated.
- a deployment mechanism, indicated generally at 90 carries sensor needle 15 which acts as a working electrode.
- Deployment mechanism 90 comprises a generally cylindrical casing 91 extending from second part 13.
- a platform 92 is movably mounted in casing 90, platform 92 carrying needle 15 on the underside thereof.
- Lower surface 14 of second part 13 is provided with an aperture 93 through which needle 15 can extend when platform 92 is caused to move downwards to the position shown in Fig. 13.
- first part 12 of device 10 can be mated with second part 13 by means of an annular recess 94 in second part 13 which received cylindrical casing 91.
- Annular recess 94 defines a cylindrical projection 95 in the centre thereof. Cylindrical projection 95 causes platform 92 to be pushed downwards within cylindrical casing 91 when first part 12 is mated to second part 13.
- a spring 96 which biases platform 92 upwards resists the mating of first part 12 to second part 13, but a snap-fit mechanism defined by a lip 97 (see also Fig.
- first part 12 and second part 13 are each provided with the requisite electrical connections (not shown) to connect the electrodes 15-17 to the electronic controlling circuitry provided in second part 13.
- the second part 13 can be a reusable electronic controller module and first part 12 can be a disposable electrode module.
- a release button 99 is provided on the second part 13.
- Fig. 13A shows a detail of the device 10 in which a lip 97, groove 98 and release button 99 can be seen more clearly.
- the release button 99 is provided with a sloped surface 100 such that when the release button 99 is pushed towards the right, the sloped surface 100 exerts a downward force on the first part 12 to release the lip 97 from the groove 98. This allows the first part 12 to disengage from the second part 13, the disengagement being assisted by the spring 96 which tends to bias the platform 92 away from the lower surface 14.
- the second part 13 can be provided with means for displaying the measured analyte level and/or with alarm means for indicating that the analyte level has passed beyond a pre-programmed limit.
- the controller can be provided with a transmitter which transmits a suitable signal to a remote receiver which is provided with a display. This allows the monitor to warn the user discreetly, with the display being readable from a wristwatch-type display unit.
- Fig. 14 shows an alternative construction of a sensor needle, indicated generally at 1 10, in which the platinum-iridium needle of Fig. 3 is replaced by a stainless steel needle shaft 11 1 on which a coating of platinum black 112 (otherwise referred to as colloidal platinum) is provided, with glucose oxidase enzyme embedded in the platinum black coating 112.
- This platinum black coating is coated by a protective polyurethane membrane 1 13 and this in turn is provided with a soluble glucose coating 114.
- the operation of the sensor needle 1 10 is essentially identical to that of the sensor needle 15 of Fig. 3, i.e. glucose reacts with oxygen and water in the presence of the enzyme embedded in the platinum black coating 1 12, thereby producing hydrogen peroxide which is catalysed by the colloidal platinum to provide free electrons.
Abstract
Description
Claims
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA002294610A CA2294610A1 (en) | 1997-06-16 | 1998-06-11 | Methods of calibrating and testing a sensor for in vivo measurement of an analyte and devices for use in such methods |
EP98928503A EP0990151A2 (en) | 1997-06-16 | 1998-06-11 | Methods of calibrating and testing a sensor for (in vivo) measurement of an analyte and devices for use in such methods |
JP50406499A JP2002505008A (en) | 1997-06-16 | 1998-06-11 | Methods for calibrating and testing sensors for in vivo measurement of analytes and devices for use in such methods |
AU80318/98A AU8031898A (en) | 1997-06-16 | 1998-06-11 | Methods of calibrating and testing a sensor for (in vivo) measurement of an analyte and devices for use in such methods |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IE970443 | 1997-06-16 | ||
IE970443A IE970443A1 (en) | 1997-06-16 | 1997-06-16 | Methods of calibrating and testing a sensor for in vivo¹measurement of an analyte and devices for use in such¹methods |
US88154797A | 1997-06-24 | 1997-06-24 | |
US08/881,547 | 1997-06-24 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO1998058250A2 true WO1998058250A2 (en) | 1998-12-23 |
WO1998058250A3 WO1998058250A3 (en) | 1999-04-01 |
Family
ID=26320061
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IE1998/000045 WO1998058250A2 (en) | 1997-06-16 | 1998-06-11 | Methods of calibrating and testing a sensor for in vivo measurement of an analyte and devices for use in such methods |
Country Status (7)
Country | Link |
---|---|
US (1) | US6275717B1 (en) |
EP (1) | EP0990151A2 (en) |
JP (1) | JP2002505008A (en) |
AU (1) | AU8031898A (en) |
CA (1) | CA2294610A1 (en) |
TW (1) | TW380046B (en) |
WO (1) | WO1998058250A2 (en) |
Cited By (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001013102A1 (en) * | 1999-08-11 | 2001-02-22 | Iit Limited | Sensor devices and analytical methods for their use |
WO2001021827A1 (en) * | 1999-09-20 | 2001-03-29 | Roche Diagnostics Corporation | Small volume biosensor for continuous analyte monitoring |
WO2001022874A1 (en) * | 1999-09-29 | 2001-04-05 | Sicel Technologies, Inc. | Methods of calibrating in vivo sensor systems using in vivo generating electrodes and related devices |
WO2001033216A1 (en) * | 1999-11-04 | 2001-05-10 | Therasense, Inc. | Small volume in vitro analyte sensor and related methods |
US6717154B2 (en) | 2000-08-02 | 2004-04-06 | Sicel Technologies, Inc. | Evaluation of irradiated foods and other items with telemetric dosimeters and associated methods |
WO2005065535A1 (en) * | 2003-12-30 | 2005-07-21 | Medtronic Minimed, Inc. | System and method for sensor recalibration |
US7045054B1 (en) | 1999-09-20 | 2006-05-16 | Roche Diagnostics Corporation | Small volume biosensor for continuous analyte monitoring |
WO2007013915A1 (en) * | 2005-07-20 | 2007-02-01 | Bayer Healthcare Llc | Gated amperometry |
EP1860432A1 (en) * | 2006-05-24 | 2007-11-28 | Bionime GmbH | A method for operating a measuring meter and a measuring meter |
US7563350B2 (en) * | 1998-10-08 | 2009-07-21 | Abbott Diabetes Care Inc. | Small volume in vitro analyte sensor |
EP2142096A1 (en) * | 2007-04-04 | 2010-01-13 | Isense Corporation | Analyte sensing device having one or more sensing electrodes |
WO2010106781A1 (en) | 2009-03-16 | 2010-09-23 | Arkray, Inc. | Method of continuously measuring substrate concentration |
US20100327886A1 (en) * | 2008-03-27 | 2010-12-30 | Toshifumi Nakamura | Measurement device, measurement system, and concentration measurement method |
US8097147B2 (en) | 2000-11-30 | 2012-01-17 | Panasonic Corporation | Method of measuring quantity of substrate |
US8721544B2 (en) | 2007-03-20 | 2014-05-13 | Roche Diagnostics Operations, Inc. | System for in-vivo measurement of an analyte concentration |
US8744776B2 (en) | 2008-12-08 | 2014-06-03 | Bayer Healthcare Llc | Method for determining analyte concentration based on complex index functions |
AU2013200069B2 (en) * | 2005-07-20 | 2014-06-05 | Ascensia Diabetes Care Holdings Ag | Gated amperometry |
US9164076B2 (en) | 2010-06-07 | 2015-10-20 | Bayer Healthcare Llc | Slope-based compensation including secondary output signals |
AU2014218413B2 (en) * | 2005-07-20 | 2016-09-15 | Ascensia Diabetes Care Holdings Ag | Gated amperometry |
US9603557B2 (en) | 2004-07-13 | 2017-03-28 | Dexcom, Inc. | Transcutaneous analyte sensor |
US9662057B2 (en) | 2000-06-27 | 2017-05-30 | Abbott Diabetes Care Inc. | Integrated sample acquisition and analyte measurement method |
CN106970135A (en) * | 2005-07-20 | 2017-07-21 | 安晟信医疗科技控股公司 | Gated amperometry |
CN107091870A (en) * | 2007-12-10 | 2017-08-25 | 安晟信医疗科技控股公司 | Determine measurement apparatus, bio-sensor system and the method for analyte concentration |
US9775806B2 (en) | 2011-09-21 | 2017-10-03 | Ascensia Diabetes Care Holdings Ag | Analysis compensation including segmented signals |
US9775543B2 (en) | 2004-07-13 | 2017-10-03 | Dexcom, Inc. | Transcutaneous analyte sensor |
AU2016213744B2 (en) * | 2005-07-20 | 2017-11-23 | Ascensia Diabetes Care Holdings Ag | Gated amperometry |
US9833143B2 (en) | 2004-05-03 | 2017-12-05 | Dexcom, Inc. | Transcutaneous analyte sensor |
US9835582B2 (en) | 2005-09-30 | 2017-12-05 | Ascensia Diabetes Care Holdings Ag | Devices using gated voltammetry methods |
US9933385B2 (en) | 2007-12-10 | 2018-04-03 | Ascensia Diabetes Care Holdings Ag | Method of using an electrochemical test sensor |
US9986942B2 (en) | 2004-07-13 | 2018-06-05 | Dexcom, Inc. | Analyte sensor |
US10067082B2 (en) | 2004-02-06 | 2018-09-04 | Ascensia Diabetes Care Holdings Ag | Biosensor for determining an analyte concentration |
US10190150B2 (en) | 2006-10-24 | 2019-01-29 | Ascensia Diabetes Care Holdings Ag | Determining analyte concentration from variant concentration distribution in measurable species |
US10314525B2 (en) | 2004-07-13 | 2019-06-11 | Dexcom, Inc. | Analyte sensor |
US10591436B2 (en) | 2010-03-22 | 2020-03-17 | Ascensia Diabetes Care Holdings Ag | Residual compensation including underfill error |
US10610137B2 (en) | 2005-03-10 | 2020-04-07 | Dexcom, Inc. | System and methods for processing analyte sensor data for sensor calibration |
US10739350B2 (en) | 2007-12-10 | 2020-08-11 | Ascensia Diabetes Care Holdings Ag | Method for determining analyte concentration based on slope-based compensation |
Families Citing this family (390)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5593852A (en) | 1993-12-02 | 1997-01-14 | Heller; Adam | Subcutaneous glucose electrode |
SE9700384D0 (en) * | 1997-02-04 | 1997-02-04 | Biacore Ab | Analytical method and apparatus |
WO1998035225A1 (en) | 1997-02-06 | 1998-08-13 | E. Heller & Company | Small volume in vitro analyte sensor |
US7192450B2 (en) | 2003-05-21 | 2007-03-20 | Dexcom, Inc. | Porous membranes for use with implantable devices |
US9155496B2 (en) | 1997-03-04 | 2015-10-13 | Dexcom, Inc. | Low oxygen in vivo analyte sensor |
US20050033132A1 (en) | 1997-03-04 | 2005-02-10 | Shults Mark C. | Analyte measuring device |
US6862465B2 (en) | 1997-03-04 | 2005-03-01 | Dexcom, Inc. | Device and method for determining analyte levels |
US7657297B2 (en) * | 2004-05-03 | 2010-02-02 | Dexcom, Inc. | Implantable analyte sensor |
US8527026B2 (en) | 1997-03-04 | 2013-09-03 | Dexcom, Inc. | Device and method for determining analyte levels |
US7899511B2 (en) | 2004-07-13 | 2011-03-01 | Dexcom, Inc. | Low oxygen in vivo analyte sensor |
US6001067A (en) | 1997-03-04 | 1999-12-14 | Shults; Mark C. | Device and method for determining analyte levels |
US6134461A (en) | 1998-03-04 | 2000-10-17 | E. Heller & Company | Electrochemical analyte |
US6103033A (en) * | 1998-03-04 | 2000-08-15 | Therasense, Inc. | Process for producing an electrochemical biosensor |
US6391005B1 (en) | 1998-03-30 | 2002-05-21 | Agilent Technologies, Inc. | Apparatus and method for penetration with shaft having a sensor for sensing penetration depth |
US8974386B2 (en) | 1998-04-30 | 2015-03-10 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US6175752B1 (en) | 1998-04-30 | 2001-01-16 | Therasense, Inc. | Analyte monitoring device and methods of use |
US8465425B2 (en) | 1998-04-30 | 2013-06-18 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US9066695B2 (en) | 1998-04-30 | 2015-06-30 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US6949816B2 (en) * | 2003-04-21 | 2005-09-27 | Motorola, Inc. | Semiconductor component having first surface area for electrically coupling to a semiconductor chip and second surface area for electrically coupling to a substrate, and method of manufacturing same |
US8480580B2 (en) | 1998-04-30 | 2013-07-09 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8346337B2 (en) | 1998-04-30 | 2013-01-01 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8688188B2 (en) | 1998-04-30 | 2014-04-01 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
PT1077636E (en) * | 1998-05-13 | 2004-06-30 | Cygnus Therapeutic Systems | SIGNAL PROCESSING FOR PHYSIOLOGICAL ANALYZES MEDICATION |
PT1117328E (en) * | 1998-09-30 | 2008-12-02 | Univ North Carolina State | Methods, systems, and associated implantable devices for dynamic monitoring of tumors |
JP3985022B2 (en) * | 1999-11-08 | 2007-10-03 | アークレイ株式会社 | Body fluid measuring device and insertion body used by being inserted into the body fluid measuring device |
US8641644B2 (en) | 2000-11-21 | 2014-02-04 | Sanofi-Aventis Deutschland Gmbh | Blood testing apparatus having a rotatable cartridge with multiple lancing elements and testing means |
US6560471B1 (en) | 2001-01-02 | 2003-05-06 | Therasense, Inc. | Analyte monitoring device and methods of use |
US7041468B2 (en) | 2001-04-02 | 2006-05-09 | Therasense, Inc. | Blood glucose tracking apparatus and methods |
US6872297B2 (en) * | 2001-05-31 | 2005-03-29 | Instrumentation Laboratory Company | Analytical instruments, biosensors and methods thereof |
EP1404233B1 (en) | 2001-06-12 | 2009-12-02 | Pelikan Technologies Inc. | Self optimizing lancing device with adaptation means to temporal variations in cutaneous properties |
US7981056B2 (en) | 2002-04-19 | 2011-07-19 | Pelikan Technologies, Inc. | Methods and apparatus for lancet actuation |
US9226699B2 (en) | 2002-04-19 | 2016-01-05 | Sanofi-Aventis Deutschland Gmbh | Body fluid sampling module with a continuous compression tissue interface surface |
US9427532B2 (en) | 2001-06-12 | 2016-08-30 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
JP4149911B2 (en) | 2001-06-12 | 2008-09-17 | ペリカン テクノロジーズ インコーポレイテッド | Electric lancet actuator |
US8337419B2 (en) | 2002-04-19 | 2012-12-25 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
EP1404235A4 (en) | 2001-06-12 | 2008-08-20 | Pelikan Technologies Inc | Method and apparatus for lancet launching device integrated onto a blood-sampling cartridge |
US7025774B2 (en) | 2001-06-12 | 2006-04-11 | Pelikan Technologies, Inc. | Tissue penetration device |
US9795747B2 (en) | 2010-06-02 | 2017-10-24 | Sanofi-Aventis Deutschland Gmbh | Methods and apparatus for lancet actuation |
US6702857B2 (en) | 2001-07-27 | 2004-03-09 | Dexcom, Inc. | Membrane for use with implantable devices |
US20030032874A1 (en) | 2001-07-27 | 2003-02-13 | Dexcom, Inc. | Sensor head for use with implantable devices |
US6952604B2 (en) * | 2001-12-21 | 2005-10-04 | Becton, Dickinson And Company | Minimally-invasive system and method for monitoring analyte levels |
US7601249B2 (en) * | 2002-02-10 | 2009-10-13 | Agamatrix, Inc. | Method and apparatus for assay of electrochemical properties |
US8260393B2 (en) | 2003-07-25 | 2012-09-04 | Dexcom, Inc. | Systems and methods for replacing signal data artifacts in a glucose sensor data stream |
US7613491B2 (en) | 2002-05-22 | 2009-11-03 | Dexcom, Inc. | Silicone based membranes for use in implantable glucose sensors |
US8010174B2 (en) | 2003-08-22 | 2011-08-30 | Dexcom, Inc. | Systems and methods for replacing signal artifacts in a glucose sensor data stream |
US9247901B2 (en) | 2003-08-22 | 2016-02-02 | Dexcom, Inc. | Systems and methods for replacing signal artifacts in a glucose sensor data stream |
US9282925B2 (en) | 2002-02-12 | 2016-03-15 | Dexcom, Inc. | Systems and methods for replacing signal artifacts in a glucose sensor data stream |
US7331931B2 (en) | 2002-04-19 | 2008-02-19 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7175642B2 (en) | 2002-04-19 | 2007-02-13 | Pelikan Technologies, Inc. | Methods and apparatus for lancet actuation |
US8784335B2 (en) | 2002-04-19 | 2014-07-22 | Sanofi-Aventis Deutschland Gmbh | Body fluid sampling device with a capacitive sensor |
US7491178B2 (en) | 2002-04-19 | 2009-02-17 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US9248267B2 (en) | 2002-04-19 | 2016-02-02 | Sanofi-Aventis Deustchland Gmbh | Tissue penetration device |
US9314194B2 (en) | 2002-04-19 | 2016-04-19 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
US7901362B2 (en) | 2002-04-19 | 2011-03-08 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7892183B2 (en) | 2002-04-19 | 2011-02-22 | Pelikan Technologies, Inc. | Method and apparatus for body fluid sampling and analyte sensing |
US8372016B2 (en) | 2002-04-19 | 2013-02-12 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for body fluid sampling and analyte sensing |
US7976476B2 (en) | 2002-04-19 | 2011-07-12 | Pelikan Technologies, Inc. | Device and method for variable speed lancet |
US7674232B2 (en) | 2002-04-19 | 2010-03-09 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7232451B2 (en) | 2002-04-19 | 2007-06-19 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US8579831B2 (en) | 2002-04-19 | 2013-11-12 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US7297122B2 (en) | 2002-04-19 | 2007-11-20 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US8360992B2 (en) | 2002-04-19 | 2013-01-29 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US7909778B2 (en) | 2002-04-19 | 2011-03-22 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7229458B2 (en) | 2002-04-19 | 2007-06-12 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US9795334B2 (en) | 2002-04-19 | 2017-10-24 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US8702624B2 (en) | 2006-09-29 | 2014-04-22 | Sanofi-Aventis Deutschland Gmbh | Analyte measurement device with a single shot actuator |
US8267870B2 (en) | 2002-04-19 | 2012-09-18 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for body fluid sampling with hybrid actuation |
US7226461B2 (en) | 2002-04-19 | 2007-06-05 | Pelikan Technologies, Inc. | Method and apparatus for a multi-use body fluid sampling device with sterility barrier release |
US8221334B2 (en) | 2002-04-19 | 2012-07-17 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US7547287B2 (en) | 2002-04-19 | 2009-06-16 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7226978B2 (en) * | 2002-05-22 | 2007-06-05 | Dexcom, Inc. | Techniques to improve polyurethane membranes for implantable glucose sensors |
USRE49221E1 (en) | 2002-06-14 | 2022-09-27 | Parker Intangibles, Llc | Single-use manifolds for automated, aseptic handling of solutions in bioprocessing applications |
US20040010207A1 (en) * | 2002-07-15 | 2004-01-15 | Flaherty J. Christopher | Self-contained, automatic transcutaneous physiologic sensing system |
US7381184B2 (en) | 2002-11-05 | 2008-06-03 | Abbott Diabetes Care Inc. | Sensor inserter assembly |
US20040120848A1 (en) * | 2002-12-20 | 2004-06-24 | Maria Teodorczyk | Method for manufacturing a sterilized and calibrated biosensor-based medical device |
US8574895B2 (en) | 2002-12-30 | 2013-11-05 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus using optical techniques to measure analyte levels |
EP1578262A4 (en) | 2002-12-31 | 2007-12-05 | Therasense Inc | Continuous glucose monitoring system and methods of use |
US7134999B2 (en) | 2003-04-04 | 2006-11-14 | Dexcom, Inc. | Optimized sensor geometry for an implantable glucose sensor |
US7415299B2 (en) * | 2003-04-18 | 2008-08-19 | The Regents Of The University Of California | Monitoring method and/or apparatus |
US7875293B2 (en) | 2003-05-21 | 2011-01-25 | Dexcom, Inc. | Biointerface membranes incorporating bioactive agents |
ES2347248T3 (en) | 2003-05-30 | 2010-10-27 | Pelikan Technologies Inc. | PROCEDURE AND APPLIANCE FOR FLUID INJECTION. |
US7850621B2 (en) | 2003-06-06 | 2010-12-14 | Pelikan Technologies, Inc. | Method and apparatus for body fluid sampling and analyte sensing |
US7258673B2 (en) * | 2003-06-06 | 2007-08-21 | Lifescan, Inc | Devices, systems and methods for extracting bodily fluid and monitoring an analyte therein |
US20040253736A1 (en) * | 2003-06-06 | 2004-12-16 | Phil Stout | Analytical device with prediction module and related methods |
US8066639B2 (en) | 2003-06-10 | 2011-11-29 | Abbott Diabetes Care Inc. | Glucose measuring device for use in personal area network |
WO2006001797A1 (en) | 2004-06-14 | 2006-01-05 | Pelikan Technologies, Inc. | Low pain penetrating |
EP1649260A4 (en) | 2003-07-25 | 2010-07-07 | Dexcom Inc | Electrode systems for electrochemical sensors |
US20050056552A1 (en) * | 2003-07-25 | 2005-03-17 | Simpson Peter C. | Increasing bias for oxygen production in an electrode system |
US7761130B2 (en) | 2003-07-25 | 2010-07-20 | Dexcom, Inc. | Dual electrode system for a continuous analyte sensor |
US8423113B2 (en) | 2003-07-25 | 2013-04-16 | Dexcom, Inc. | Systems and methods for processing sensor data |
JP4708342B2 (en) | 2003-07-25 | 2011-06-22 | デックスコム・インコーポレーテッド | Oxygen augmentation membrane system for use in implantable devices |
US8626257B2 (en) | 2003-08-01 | 2014-01-07 | Dexcom, Inc. | Analyte sensor |
US8845536B2 (en) | 2003-08-01 | 2014-09-30 | Dexcom, Inc. | Transcutaneous analyte sensor |
US7925321B2 (en) | 2003-08-01 | 2011-04-12 | Dexcom, Inc. | System and methods for processing analyte sensor data |
US7774145B2 (en) | 2003-08-01 | 2010-08-10 | Dexcom, Inc. | Transcutaneous analyte sensor |
US8369919B2 (en) | 2003-08-01 | 2013-02-05 | Dexcom, Inc. | Systems and methods for processing sensor data |
US8160669B2 (en) | 2003-08-01 | 2012-04-17 | Dexcom, Inc. | Transcutaneous analyte sensor |
US6931327B2 (en) | 2003-08-01 | 2005-08-16 | Dexcom, Inc. | System and methods for processing analyte sensor data |
US20100168657A1 (en) | 2003-08-01 | 2010-07-01 | Dexcom, Inc. | System and methods for processing analyte sensor data |
US7591801B2 (en) | 2004-02-26 | 2009-09-22 | Dexcom, Inc. | Integrated delivery device for continuous glucose sensor |
US20190357827A1 (en) | 2003-08-01 | 2019-11-28 | Dexcom, Inc. | Analyte sensor |
US8886273B2 (en) | 2003-08-01 | 2014-11-11 | Dexcom, Inc. | Analyte sensor |
US8761856B2 (en) | 2003-08-01 | 2014-06-24 | Dexcom, Inc. | System and methods for processing analyte sensor data |
US8275437B2 (en) | 2003-08-01 | 2012-09-25 | Dexcom, Inc. | Transcutaneous analyte sensor |
US9135402B2 (en) | 2007-12-17 | 2015-09-15 | Dexcom, Inc. | Systems and methods for processing sensor data |
US20140121989A1 (en) | 2003-08-22 | 2014-05-01 | Dexcom, Inc. | Systems and methods for processing analyte sensor data |
EP1671096A4 (en) | 2003-09-29 | 2009-09-16 | Pelikan Technologies Inc | Method and apparatus for an improved sample capture device |
WO2005037095A1 (en) | 2003-10-14 | 2005-04-28 | Pelikan Technologies, Inc. | Method and apparatus for a variable user interface |
US7299082B2 (en) * | 2003-10-31 | 2007-11-20 | Abbott Diabetes Care, Inc. | Method of calibrating an analyte-measurement device, and associated methods, devices and systems |
USD902408S1 (en) | 2003-11-05 | 2020-11-17 | Abbott Diabetes Care Inc. | Analyte sensor control unit |
WO2005051170A2 (en) | 2003-11-19 | 2005-06-09 | Dexcom, Inc. | Integrated receiver for continuous analyte sensor |
US8425417B2 (en) | 2003-12-05 | 2013-04-23 | Dexcom, Inc. | Integrated device for continuous in vivo analyte detection and simultaneous control of an infusion device |
US8425416B2 (en) | 2006-10-04 | 2013-04-23 | Dexcom, Inc. | Analyte sensor |
US8423114B2 (en) | 2006-10-04 | 2013-04-16 | Dexcom, Inc. | Dual electrode system for a continuous analyte sensor |
US8774886B2 (en) | 2006-10-04 | 2014-07-08 | Dexcom, Inc. | Analyte sensor |
EP2239566B1 (en) | 2003-12-05 | 2014-04-23 | DexCom, Inc. | Calibration techniques for a continuous analyte sensor |
US8364230B2 (en) | 2006-10-04 | 2013-01-29 | Dexcom, Inc. | Analyte sensor |
US11633133B2 (en) | 2003-12-05 | 2023-04-25 | Dexcom, Inc. | Dual electrode system for a continuous analyte sensor |
US8287453B2 (en) | 2003-12-05 | 2012-10-16 | Dexcom, Inc. | Analyte sensor |
US8364231B2 (en) | 2006-10-04 | 2013-01-29 | Dexcom, Inc. | Analyte sensor |
ES2646312T3 (en) * | 2003-12-08 | 2017-12-13 | Dexcom, Inc. | Systems and methods to improve electromechanical analyte sensors |
WO2005057175A2 (en) | 2003-12-09 | 2005-06-23 | Dexcom, Inc. | Signal processing for continuous analyte sensor |
US8224410B2 (en) * | 2003-12-22 | 2012-07-17 | Hadvary Paul | Dermally affixed sensor device |
US8668656B2 (en) | 2003-12-31 | 2014-03-11 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for improving fluidic flow and sample capture |
US7822454B1 (en) | 2005-01-03 | 2010-10-26 | Pelikan Technologies, Inc. | Fluid sampling device with improved analyte detecting member configuration |
US7637868B2 (en) * | 2004-01-12 | 2009-12-29 | Dexcom, Inc. | Composite material for implantable device |
CA2556331A1 (en) | 2004-02-17 | 2005-09-29 | Therasense, Inc. | Method and system for providing data communication in continuous glucose monitoring and management system |
US8808228B2 (en) | 2004-02-26 | 2014-08-19 | Dexcom, Inc. | Integrated medicament delivery device for use with continuous analyte sensor |
US8277713B2 (en) | 2004-05-03 | 2012-10-02 | Dexcom, Inc. | Implantable analyte sensor |
EP1751546A2 (en) | 2004-05-20 | 2007-02-14 | Albatros Technologies GmbH & Co. KG | Printable hydrogel for biosensors |
WO2005120365A1 (en) | 2004-06-03 | 2005-12-22 | Pelikan Technologies, Inc. | Method and apparatus for a fluid sampling device |
US9775553B2 (en) | 2004-06-03 | 2017-10-03 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for a fluid sampling device |
EP1810185A4 (en) | 2004-06-04 | 2010-01-06 | Therasense Inc | Diabetes care host-client architecture and data management system |
US20060015020A1 (en) * | 2004-07-06 | 2006-01-19 | Dexcom, Inc. | Systems and methods for manufacture of an analyte-measuring device including a membrane system |
US8452368B2 (en) | 2004-07-13 | 2013-05-28 | Dexcom, Inc. | Transcutaneous analyte sensor |
EP3666187B1 (en) * | 2004-07-13 | 2021-05-26 | DexCom, Inc. | Transcutaneous analyte sensor |
US7857760B2 (en) | 2004-07-13 | 2010-12-28 | Dexcom, Inc. | Analyte sensor |
US20060016700A1 (en) * | 2004-07-13 | 2006-01-26 | Dexcom, Inc. | Transcutaneous analyte sensor |
US7783333B2 (en) | 2004-07-13 | 2010-08-24 | Dexcom, Inc. | Transcutaneous medical device with variable stiffness |
US9788771B2 (en) | 2006-10-23 | 2017-10-17 | Abbott Diabetes Care Inc. | Variable speed sensor insertion devices and methods of use |
US8571624B2 (en) | 2004-12-29 | 2013-10-29 | Abbott Diabetes Care Inc. | Method and apparatus for mounting a data transmission device in a communication system |
US8029441B2 (en) | 2006-02-28 | 2011-10-04 | Abbott Diabetes Care Inc. | Analyte sensor transmitter unit configuration for a data monitoring and management system |
US10226207B2 (en) | 2004-12-29 | 2019-03-12 | Abbott Diabetes Care Inc. | Sensor inserter having introducer |
US7883464B2 (en) | 2005-09-30 | 2011-02-08 | Abbott Diabetes Care Inc. | Integrated transmitter unit and sensor introducer mechanism and methods of use |
US8333714B2 (en) | 2006-09-10 | 2012-12-18 | Abbott Diabetes Care Inc. | Method and system for providing an integrated analyte sensor insertion device and data processing unit |
US9351669B2 (en) | 2009-09-30 | 2016-05-31 | Abbott Diabetes Care Inc. | Interconnect for on-body analyte monitoring device |
US7731657B2 (en) | 2005-08-30 | 2010-06-08 | Abbott Diabetes Care Inc. | Analyte sensor introducer and methods of use |
US7697967B2 (en) | 2005-12-28 | 2010-04-13 | Abbott Diabetes Care Inc. | Method and apparatus for providing analyte sensor insertion |
US9398882B2 (en) * | 2005-09-30 | 2016-07-26 | Abbott Diabetes Care Inc. | Method and apparatus for providing analyte sensor and data processing device |
US8613703B2 (en) | 2007-05-31 | 2013-12-24 | Abbott Diabetes Care Inc. | Insertion devices and methods |
US9259175B2 (en) | 2006-10-23 | 2016-02-16 | Abbott Diabetes Care, Inc. | Flexible patch for fluid delivery and monitoring body analytes |
US9743862B2 (en) | 2011-03-31 | 2017-08-29 | Abbott Diabetes Care Inc. | Systems and methods for transcutaneously implanting medical devices |
US9572534B2 (en) | 2010-06-29 | 2017-02-21 | Abbott Diabetes Care Inc. | Devices, systems and methods for on-skin or on-body mounting of medical devices |
US20090105569A1 (en) | 2006-04-28 | 2009-04-23 | Abbott Diabetes Care, Inc. | Introducer Assembly and Methods of Use |
US8512243B2 (en) | 2005-09-30 | 2013-08-20 | Abbott Diabetes Care Inc. | Integrated introducer and transmitter assembly and methods of use |
US9636450B2 (en) | 2007-02-19 | 2017-05-02 | Udo Hoss | Pump system modular components for delivering medication and analyte sensing at seperate insertion sites |
US8652831B2 (en) | 2004-12-30 | 2014-02-18 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for analyte measurement test time |
US8133178B2 (en) | 2006-02-22 | 2012-03-13 | Dexcom, Inc. | Analyte sensor |
US20090076360A1 (en) | 2007-09-13 | 2009-03-19 | Dexcom, Inc. | Transcutaneous analyte sensor |
WO2006105146A2 (en) * | 2005-03-29 | 2006-10-05 | Arkal Medical, Inc. | Devices, systems, methods and tools for continuous glucose monitoring |
DE502005002216D1 (en) * | 2005-04-08 | 2008-01-24 | Roche Diagnostics Gmbh | Device for placing a probe in living tissue |
US8744546B2 (en) | 2005-05-05 | 2014-06-03 | Dexcom, Inc. | Cellulosic-based resistance domain for an analyte sensor |
US8060174B2 (en) | 2005-04-15 | 2011-11-15 | Dexcom, Inc. | Analyte sensing biointerface |
EP1874179A2 (en) * | 2005-04-25 | 2008-01-09 | Infotonics Technology Center, Inc. | Microneedle with glucose sensor and method thereof |
US8112240B2 (en) | 2005-04-29 | 2012-02-07 | Abbott Diabetes Care Inc. | Method and apparatus for providing leak detection in data monitoring and management systems |
US8840586B2 (en) * | 2006-08-23 | 2014-09-23 | Medtronic Minimed, Inc. | Systems and methods allowing for reservoir filling and infusion medium delivery |
US7905868B2 (en) | 2006-08-23 | 2011-03-15 | Medtronic Minimed, Inc. | Infusion medium delivery device and method with drive device for driving plunger in reservoir |
US20080097291A1 (en) * | 2006-08-23 | 2008-04-24 | Hanson Ian B | Infusion pumps and methods and delivery devices and methods with same |
US8137314B2 (en) * | 2006-08-23 | 2012-03-20 | Medtronic Minimed, Inc. | Infusion medium delivery device and method with compressible or curved reservoir or conduit |
US7641649B2 (en) * | 2005-05-06 | 2010-01-05 | Medtronic Minimed, Inc. | Reservoir support and method for infusion device |
US8512288B2 (en) | 2006-08-23 | 2013-08-20 | Medtronic Minimed, Inc. | Infusion medium delivery device and method with drive device for driving plunger in reservoir |
US8277415B2 (en) | 2006-08-23 | 2012-10-02 | Medtronic Minimed, Inc. | Infusion medium delivery device and method with drive device for driving plunger in reservoir |
CN101365374B (en) | 2005-08-31 | 2011-11-16 | 弗吉尼亚大学专利基金委员会 | Improving accuracy of continuous glucose sensors |
US8880138B2 (en) | 2005-09-30 | 2014-11-04 | Abbott Diabetes Care Inc. | Device for channeling fluid and methods of use |
US9521968B2 (en) | 2005-09-30 | 2016-12-20 | Abbott Diabetes Care Inc. | Analyte sensor retention mechanism and methods of use |
US7766829B2 (en) | 2005-11-04 | 2010-08-03 | Abbott Diabetes Care Inc. | Method and system for providing basal profile modification in analyte monitoring and management systems |
US9615851B2 (en) * | 2005-11-11 | 2017-04-11 | Waveform Technologies, Inc. | Method and apparatus for insertion of a sensor |
US7857506B2 (en) * | 2005-12-05 | 2010-12-28 | Sencal Llc | Disposable, pre-calibrated, pre-validated sensors for use in bio-processing applications |
DE102005062388A1 (en) * | 2005-12-23 | 2007-06-28 | Endress + Hauser Conducta Gesellschaft für Mess- und Regeltechnik mbH + Co. KG | Measuring device e.g. turbidity measuring device, for laboratory reference process, involves updating instruction based on actual calibration and reference measuring values, where earlier values pair is considered for updating instructions |
US8160670B2 (en) * | 2005-12-28 | 2012-04-17 | Abbott Diabetes Care Inc. | Analyte monitoring: stabilizer for subcutaneous glucose sensor with incorporated antiglycolytic agent |
US11298058B2 (en) | 2005-12-28 | 2022-04-12 | Abbott Diabetes Care Inc. | Method and apparatus for providing analyte sensor insertion |
CA2636034A1 (en) | 2005-12-28 | 2007-10-25 | Abbott Diabetes Care Inc. | Medical device insertion |
US8515518B2 (en) * | 2005-12-28 | 2013-08-20 | Abbott Diabetes Care Inc. | Analyte monitoring |
US7519409B2 (en) * | 2005-12-29 | 2009-04-14 | Medtronic, Inc. | Implantable cell/tissue-based biosensing device |
US7774038B2 (en) | 2005-12-30 | 2010-08-10 | Medtronic Minimed, Inc. | Real-time self-calibrating sensor system and method |
US9757061B2 (en) | 2006-01-17 | 2017-09-12 | Dexcom, Inc. | Low oxygen in vivo analyte sensor |
US7736310B2 (en) | 2006-01-30 | 2010-06-15 | Abbott Diabetes Care Inc. | On-body medical device securement |
WO2007092637A2 (en) | 2006-02-09 | 2007-08-16 | Deka Products Limited Partnership | Patch-sized fluid delivery systems and methods |
US7826879B2 (en) | 2006-02-28 | 2010-11-02 | Abbott Diabetes Care Inc. | Analyte sensors and methods of use |
US7885698B2 (en) | 2006-02-28 | 2011-02-08 | Abbott Diabetes Care Inc. | Method and system for providing continuous calibration of implantable analyte sensors |
EP1991110B1 (en) | 2006-03-09 | 2018-11-07 | DexCom, Inc. | Systems and methods for processing analyte sensor data |
US20080154107A1 (en) * | 2006-12-20 | 2008-06-26 | Jina Arvind N | Device, systems, methods and tools for continuous glucose monitoring |
US20100049021A1 (en) * | 2006-03-28 | 2010-02-25 | Jina Arvind N | Devices, systems, methods and tools for continuous analyte monitoring |
US8346335B2 (en) | 2008-03-28 | 2013-01-01 | Abbott Diabetes Care Inc. | Analyte sensor calibration management |
US7618369B2 (en) | 2006-10-02 | 2009-11-17 | Abbott Diabetes Care Inc. | Method and system for dynamically updating calibration parameters for an analyte sensor |
US7620438B2 (en) | 2006-03-31 | 2009-11-17 | Abbott Diabetes Care Inc. | Method and system for powering an electronic device |
US9392969B2 (en) | 2008-08-31 | 2016-07-19 | Abbott Diabetes Care Inc. | Closed loop control and signal attenuation detection |
US8374668B1 (en) | 2007-10-23 | 2013-02-12 | Abbott Diabetes Care Inc. | Analyte sensor with lag compensation |
US8140312B2 (en) | 2007-05-14 | 2012-03-20 | Abbott Diabetes Care Inc. | Method and system for determining analyte levels |
US8473022B2 (en) | 2008-01-31 | 2013-06-25 | Abbott Diabetes Care Inc. | Analyte sensor with time lag compensation |
US9675290B2 (en) | 2012-10-30 | 2017-06-13 | Abbott Diabetes Care Inc. | Sensitivity calibration of in vivo sensors used to measure analyte concentration |
US7801582B2 (en) | 2006-03-31 | 2010-09-21 | Abbott Diabetes Care Inc. | Analyte monitoring and management system and methods therefor |
US8224415B2 (en) | 2009-01-29 | 2012-07-17 | Abbott Diabetes Care Inc. | Method and device for providing offset model based calibration for analyte sensor |
US9326709B2 (en) | 2010-03-10 | 2016-05-03 | Abbott Diabetes Care Inc. | Systems, devices and methods for managing glucose levels |
US8226891B2 (en) | 2006-03-31 | 2012-07-24 | Abbott Diabetes Care Inc. | Analyte monitoring devices and methods therefor |
US8219173B2 (en) | 2008-09-30 | 2012-07-10 | Abbott Diabetes Care Inc. | Optimizing analyte sensor calibration |
US7630748B2 (en) | 2006-10-25 | 2009-12-08 | Abbott Diabetes Care Inc. | Method and system for providing analyte monitoring |
US7653425B2 (en) | 2006-08-09 | 2010-01-26 | Abbott Diabetes Care Inc. | Method and system for providing calibration of an analyte sensor in an analyte monitoring system |
WO2007120381A2 (en) | 2006-04-14 | 2007-10-25 | Dexcom, Inc. | Analyte sensor |
WO2007143225A2 (en) * | 2006-06-07 | 2007-12-13 | Abbott Diabetes Care, Inc. | Analyte monitoring system and method |
US7794434B2 (en) * | 2006-08-23 | 2010-09-14 | Medtronic Minimed, Inc. | Systems and methods allowing for reservoir filling and infusion medium delivery |
US7811262B2 (en) * | 2006-08-23 | 2010-10-12 | Medtronic Minimed, Inc. | Systems and methods allowing for reservoir filling and infusion medium delivery |
US20080051765A1 (en) * | 2006-08-23 | 2008-02-28 | Medtronic Minimed, Inc. | Systems and methods allowing for reservoir filling and infusion medium delivery |
US7828764B2 (en) * | 2006-08-23 | 2010-11-09 | Medtronic Minimed, Inc. | Systems and methods allowing for reservoir filling and infusion medium delivery |
US7789857B2 (en) * | 2006-08-23 | 2010-09-07 | Medtronic Minimed, Inc. | Infusion medium delivery system, device and method with needle inserter and needle inserter device and method |
US20080058726A1 (en) * | 2006-08-30 | 2008-03-06 | Arvind Jina | Methods and Apparatus Incorporating a Surface Penetration Device |
US8562528B2 (en) | 2006-10-04 | 2013-10-22 | Dexcom, Inc. | Analyte sensor |
US8478377B2 (en) | 2006-10-04 | 2013-07-02 | Dexcom, Inc. | Analyte sensor |
US8298142B2 (en) | 2006-10-04 | 2012-10-30 | Dexcom, Inc. | Analyte sensor |
US7831287B2 (en) | 2006-10-04 | 2010-11-09 | Dexcom, Inc. | Dual electrode system for a continuous analyte sensor |
US8447376B2 (en) | 2006-10-04 | 2013-05-21 | Dexcom, Inc. | Analyte sensor |
US8275438B2 (en) | 2006-10-04 | 2012-09-25 | Dexcom, Inc. | Analyte sensor |
US8449464B2 (en) | 2006-10-04 | 2013-05-28 | Dexcom, Inc. | Analyte sensor |
US7880626B2 (en) * | 2006-10-12 | 2011-02-01 | Masimo Corporation | System and method for monitoring the life of a physiological sensor |
JP2010508091A (en) | 2006-10-26 | 2010-03-18 | アボット ダイアベティス ケア インコーポレイテッド | Method, system, and computer program product for detecting in real time a decrease in sensitivity of an analyte sensor |
EP2124726A1 (en) * | 2006-12-22 | 2009-12-02 | Medingo Ltd. | Fluid delivery with in vivo electrochemical analyte sensing |
US8845530B2 (en) * | 2007-01-02 | 2014-09-30 | Isense Corporation | Resposable biosensor assembly and method of sensing |
US20080199894A1 (en) | 2007-02-15 | 2008-08-21 | Abbott Diabetes Care, Inc. | Device and method for automatic data acquisition and/or detection |
US8121857B2 (en) | 2007-02-15 | 2012-02-21 | Abbott Diabetes Care Inc. | Device and method for automatic data acquisition and/or detection |
US8732188B2 (en) | 2007-02-18 | 2014-05-20 | Abbott Diabetes Care Inc. | Method and system for providing contextual based medication dosage determination |
US8930203B2 (en) | 2007-02-18 | 2015-01-06 | Abbott Diabetes Care Inc. | Multi-function analyte test device and methods therefor |
US8123686B2 (en) | 2007-03-01 | 2012-02-28 | Abbott Diabetes Care Inc. | Method and apparatus for providing rolling data in communication systems |
WO2008130895A2 (en) | 2007-04-14 | 2008-10-30 | Abbott Diabetes Care, Inc. | Method and apparatus for providing dynamic multi-stage signal amplification in a medical device |
CA2683953C (en) | 2007-04-14 | 2016-08-02 | Abbott Diabetes Care Inc. | Method and apparatus for providing data processing and control in medical communication system |
US9615780B2 (en) | 2007-04-14 | 2017-04-11 | Abbott Diabetes Care Inc. | Method and apparatus for providing data processing and control in medical communication system |
ES2817503T3 (en) | 2007-04-14 | 2021-04-07 | Abbott Diabetes Care Inc | Procedure and apparatus for providing data processing and control in a medical communication system |
CA2683930A1 (en) | 2007-04-14 | 2008-10-23 | Abbott Diabetes Care Inc. | Method and apparatus for providing data processing and control in medical communication system |
WO2008130898A1 (en) | 2007-04-14 | 2008-10-30 | Abbott Diabetes Care, Inc. | Method and apparatus for providing data processing and control in medical communication system |
US8597243B2 (en) | 2007-04-30 | 2013-12-03 | Medtronic Minimed, Inc. | Systems and methods allowing for reservoir air bubble management |
US8434528B2 (en) | 2007-04-30 | 2013-05-07 | Medtronic Minimed, Inc. | Systems and methods for reservoir filling |
US7963954B2 (en) | 2007-04-30 | 2011-06-21 | Medtronic Minimed, Inc. | Automated filling systems and methods |
US7959715B2 (en) | 2007-04-30 | 2011-06-14 | Medtronic Minimed, Inc. | Systems and methods allowing for reservoir air bubble management |
US8323250B2 (en) | 2007-04-30 | 2012-12-04 | Medtronic Minimed, Inc. | Adhesive patch systems and methods |
US8613725B2 (en) | 2007-04-30 | 2013-12-24 | Medtronic Minimed, Inc. | Reservoir systems and methods |
WO2008136845A2 (en) | 2007-04-30 | 2008-11-13 | Medtronic Minimed, Inc. | Reservoir filling, bubble management, and infusion medium delivery systems and methods with same |
US7928850B2 (en) | 2007-05-08 | 2011-04-19 | Abbott Diabetes Care Inc. | Analyte monitoring system and methods |
US8456301B2 (en) | 2007-05-08 | 2013-06-04 | Abbott Diabetes Care Inc. | Analyte monitoring system and methods |
US8665091B2 (en) | 2007-05-08 | 2014-03-04 | Abbott Diabetes Care Inc. | Method and device for determining elapsed sensor life |
US8461985B2 (en) | 2007-05-08 | 2013-06-11 | Abbott Diabetes Care Inc. | Analyte monitoring system and methods |
US8260558B2 (en) | 2007-05-14 | 2012-09-04 | Abbott Diabetes Care Inc. | Method and apparatus for providing data processing and control in a medical communication system |
US9125548B2 (en) | 2007-05-14 | 2015-09-08 | Abbott Diabetes Care Inc. | Method and apparatus for providing data processing and control in a medical communication system |
US8600681B2 (en) | 2007-05-14 | 2013-12-03 | Abbott Diabetes Care Inc. | Method and apparatus for providing data processing and control in a medical communication system |
US8444560B2 (en) | 2007-05-14 | 2013-05-21 | Abbott Diabetes Care Inc. | Method and apparatus for providing data processing and control in a medical communication system |
US10002233B2 (en) | 2007-05-14 | 2018-06-19 | Abbott Diabetes Care Inc. | Method and apparatus for providing data processing and control in a medical communication system |
US7996158B2 (en) | 2007-05-14 | 2011-08-09 | Abbott Diabetes Care Inc. | Method and apparatus for providing data processing and control in a medical communication system |
US8239166B2 (en) | 2007-05-14 | 2012-08-07 | Abbott Diabetes Care Inc. | Method and apparatus for providing data processing and control in a medical communication system |
US8103471B2 (en) | 2007-05-14 | 2012-01-24 | Abbott Diabetes Care Inc. | Method and apparatus for providing data processing and control in a medical communication system |
US8560038B2 (en) | 2007-05-14 | 2013-10-15 | Abbott Diabetes Care Inc. | Method and apparatus for providing data processing and control in a medical communication system |
CA2688184A1 (en) | 2007-06-08 | 2008-12-18 | Dexcom, Inc. | Integrated medicament delivery device for use with continuous analyte sensor |
US20080312518A1 (en) * | 2007-06-14 | 2008-12-18 | Arkal Medical, Inc | On-demand analyte monitor and method of use |
JP2010531169A (en) | 2007-06-21 | 2010-09-24 | アボット ダイアベティス ケア インコーポレイテッド | Health monitoring device |
AU2008265541B2 (en) | 2007-06-21 | 2014-07-17 | Abbott Diabetes Care, Inc. | Health management devices and methods |
US8160900B2 (en) | 2007-06-29 | 2012-04-17 | Abbott Diabetes Care Inc. | Analyte monitoring and management device and method to analyze the frequency of user interaction with the device |
US7768386B2 (en) | 2007-07-31 | 2010-08-03 | Abbott Diabetes Care Inc. | Method and apparatus for providing data processing and control in a medical communication system |
US8834366B2 (en) | 2007-07-31 | 2014-09-16 | Abbott Diabetes Care Inc. | Method and apparatus for providing analyte sensor calibration |
PL2535706T3 (en) | 2007-09-24 | 2015-11-30 | Bayer Healthcare Llc | Multi-electrode test sensor |
US9452258B2 (en) | 2007-10-09 | 2016-09-27 | Dexcom, Inc. | Integrated insulin delivery system with continuous glucose sensor |
US8216138B1 (en) | 2007-10-23 | 2012-07-10 | Abbott Diabetes Care Inc. | Correlation of alternative site blood and interstitial fluid glucose concentrations to venous glucose concentration |
US8409093B2 (en) | 2007-10-23 | 2013-04-02 | Abbott Diabetes Care Inc. | Assessing measures of glycemic variability |
US8377031B2 (en) | 2007-10-23 | 2013-02-19 | Abbott Diabetes Care Inc. | Closed loop control system with safety parameters and methods |
US8417312B2 (en) | 2007-10-25 | 2013-04-09 | Dexcom, Inc. | Systems and methods for processing sensor data |
US9839395B2 (en) | 2007-12-17 | 2017-12-12 | Dexcom, Inc. | Systems and methods for processing sensor data |
US20090164239A1 (en) | 2007-12-19 | 2009-06-25 | Abbott Diabetes Care, Inc. | Dynamic Display Of Glucose Information |
US8986253B2 (en) | 2008-01-25 | 2015-03-24 | Tandem Diabetes Care, Inc. | Two chamber pumps and related methods |
CA2715628A1 (en) | 2008-02-21 | 2009-08-27 | Dexcom, Inc. | Systems and methods for processing, transmitting and displaying sensor data |
US8968345B2 (en) * | 2008-03-24 | 2015-03-03 | Covidien Lp | Surgical introducer with indicators |
US8396528B2 (en) | 2008-03-25 | 2013-03-12 | Dexcom, Inc. | Analyte sensor |
US8682408B2 (en) | 2008-03-28 | 2014-03-25 | Dexcom, Inc. | Polymer membranes for continuous analyte sensors |
US11730407B2 (en) | 2008-03-28 | 2023-08-22 | Dexcom, Inc. | Polymer membranes for continuous analyte sensors |
US8583204B2 (en) | 2008-03-28 | 2013-11-12 | Dexcom, Inc. | Polymer membranes for continuous analyte sensors |
US8252229B2 (en) | 2008-04-10 | 2012-08-28 | Abbott Diabetes Care Inc. | Method and system for sterilizing an analyte sensor |
WO2009126900A1 (en) | 2008-04-11 | 2009-10-15 | Pelikan Technologies, Inc. | Method and apparatus for analyte detecting device |
US9295786B2 (en) | 2008-05-28 | 2016-03-29 | Medtronic Minimed, Inc. | Needle protective device for subcutaneous sensors |
US8591410B2 (en) | 2008-05-30 | 2013-11-26 | Abbott Diabetes Care Inc. | Method and apparatus for providing glycemic control |
US7826382B2 (en) | 2008-05-30 | 2010-11-02 | Abbott Diabetes Care Inc. | Close proximity communication device and methods |
US8924159B2 (en) | 2008-05-30 | 2014-12-30 | Abbott Diabetes Care Inc. | Method and apparatus for providing glycemic control |
CN102089650B (en) | 2008-07-10 | 2014-01-29 | 拜尔健康护理有限责任公司 | Systems and methods including amperometric and voltammetric duty cycles |
US8876755B2 (en) | 2008-07-14 | 2014-11-04 | Abbott Diabetes Care Inc. | Closed loop control system interface and methods |
US8622988B2 (en) | 2008-08-31 | 2014-01-07 | Abbott Diabetes Care Inc. | Variable rate closed loop control and methods |
US9943644B2 (en) | 2008-08-31 | 2018-04-17 | Abbott Diabetes Care Inc. | Closed loop control with reference measurement and methods thereof |
US8734422B2 (en) | 2008-08-31 | 2014-05-27 | Abbott Diabetes Care Inc. | Closed loop control with improved alarm functions |
US20100057040A1 (en) | 2008-08-31 | 2010-03-04 | Abbott Diabetes Care, Inc. | Robust Closed Loop Control And Methods |
US8408421B2 (en) | 2008-09-16 | 2013-04-02 | Tandem Diabetes Care, Inc. | Flow regulating stopcocks and related methods |
US8560039B2 (en) | 2008-09-19 | 2013-10-15 | Dexcom, Inc. | Particle-containing membrane and particulate electrode for analyte sensors |
EP2334234A4 (en) | 2008-09-19 | 2013-03-20 | Tandem Diabetes Care Inc | Solute concentration measurement device and related methods |
US8986208B2 (en) | 2008-09-30 | 2015-03-24 | Abbott Diabetes Care Inc. | Analyte sensor sensitivity attenuation mitigation |
US9801575B2 (en) | 2011-04-15 | 2017-10-31 | Dexcom, Inc. | Advanced analyte sensor calibration and error detection |
US9326707B2 (en) | 2008-11-10 | 2016-05-03 | Abbott Diabetes Care Inc. | Alarm characterization for analyte monitoring devices and systems |
US20100169035A1 (en) * | 2008-12-29 | 2010-07-01 | Medtronic Minimed, Inc. | Methods and systems for observing sensor parameters |
WO2010080715A1 (en) | 2009-01-12 | 2010-07-15 | Becton, Dickinson And Company | Infusion set and/or patch pump having at least one of an in-dwelling rigid catheter with flexible features and/or a flexible catheter attachment |
US9375529B2 (en) | 2009-09-02 | 2016-06-28 | Becton, Dickinson And Company | Extended use medical device |
US8103456B2 (en) | 2009-01-29 | 2012-01-24 | Abbott Diabetes Care Inc. | Method and device for early signal attenuation detection using blood glucose measurements |
US9375169B2 (en) | 2009-01-30 | 2016-06-28 | Sanofi-Aventis Deutschland Gmbh | Cam drive for managing disposable penetrating member actions with a single motor and motor and control system |
US9402544B2 (en) | 2009-02-03 | 2016-08-02 | Abbott Diabetes Care Inc. | Analyte sensor and apparatus for insertion of the sensor |
US9446194B2 (en) | 2009-03-27 | 2016-09-20 | Dexcom, Inc. | Methods and systems for promoting glucose management |
US8497777B2 (en) | 2009-04-15 | 2013-07-30 | Abbott Diabetes Care Inc. | Analyte monitoring system having an alert |
EP2419015A4 (en) | 2009-04-16 | 2014-08-20 | Abbott Diabetes Care Inc | Analyte sensor calibration management |
US9226701B2 (en) | 2009-04-28 | 2016-01-05 | Abbott Diabetes Care Inc. | Error detection in critical repeating data in a wireless sensor system |
US8483967B2 (en) | 2009-04-29 | 2013-07-09 | Abbott Diabetes Care Inc. | Method and system for providing real time analyte sensor calibration with retrospective backfill |
US8368556B2 (en) | 2009-04-29 | 2013-02-05 | Abbott Diabetes Care Inc. | Method and system for providing data communication in continuous glucose monitoring and management system |
US8571619B2 (en) | 2009-05-20 | 2013-10-29 | Masimo Corporation | Hemoglobin display and patient treatment |
WO2010138856A1 (en) | 2009-05-29 | 2010-12-02 | Abbott Diabetes Care Inc. | Medical device antenna systems having external antenna configurations |
US8613892B2 (en) | 2009-06-30 | 2013-12-24 | Abbott Diabetes Care Inc. | Analyte meter with a moveable head and methods of using the same |
EP4289355A3 (en) | 2009-07-23 | 2024-02-28 | Abbott Diabetes Care Inc. | Continuous analyte measurement system |
US8939928B2 (en) | 2009-07-23 | 2015-01-27 | Becton, Dickinson And Company | Medical device having capacitive coupling communication and energy harvesting |
CA2921304C (en) | 2009-07-30 | 2018-06-05 | Tandem Diabetes Care, Inc. | Infusion pump system with disposable cartridge having pressure venting and pressure feedback |
WO2011014851A1 (en) | 2009-07-31 | 2011-02-03 | Abbott Diabetes Care Inc. | Method and apparatus for providing analyte monitoring system calibration accuracy |
EP4070728A1 (en) | 2009-08-31 | 2022-10-12 | Abbott Diabetes Care, Inc. | Displays for a medical device |
AU2010286917B2 (en) | 2009-08-31 | 2016-03-10 | Abbott Diabetes Care Inc. | Medical devices and methods |
US9314195B2 (en) | 2009-08-31 | 2016-04-19 | Abbott Diabetes Care Inc. | Analyte signal processing device and methods |
EP2473099A4 (en) | 2009-08-31 | 2015-01-14 | Abbott Diabetes Care Inc | Analyte monitoring system and methods for managing power and noise |
US10092691B2 (en) | 2009-09-02 | 2018-10-09 | Becton, Dickinson And Company | Flexible and conformal patch pump |
WO2011041469A1 (en) | 2009-09-29 | 2011-04-07 | Abbott Diabetes Care Inc. | Method and apparatus for providing notification function in analyte monitoring systems |
CN102724913A (en) * | 2009-09-30 | 2012-10-10 | 德克斯康公司 | Transcutaneous analyte sensor |
US20110082356A1 (en) * | 2009-10-01 | 2011-04-07 | Medtronic Minimed, Inc. | Analyte sensor apparatuses having interference rejection membranes and methods for making and using them |
EP2494323A4 (en) | 2009-10-30 | 2014-07-16 | Abbott Diabetes Care Inc | Method and apparatus for detecting false hypoglycemic conditions |
US8264215B1 (en) * | 2009-12-10 | 2012-09-11 | The Boeing Company | Onboard electrical current sensing system |
USD924406S1 (en) | 2010-02-01 | 2021-07-06 | Abbott Diabetes Care Inc. | Analyte sensor inserter |
CA3096110C (en) | 2010-03-24 | 2023-11-14 | Abbott Diabetes Care Inc. | Medical device inserters and processes of inserting and using medical devices |
US8965476B2 (en) | 2010-04-16 | 2015-02-24 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
AU2011239548A1 (en) | 2010-04-16 | 2012-01-19 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods |
US8635046B2 (en) | 2010-06-23 | 2014-01-21 | Abbott Diabetes Care Inc. | Method and system for evaluating analyte sensor response characteristics |
US11064921B2 (en) | 2010-06-29 | 2021-07-20 | Abbott Diabetes Care Inc. | Devices, systems and methods for on-skin or on-body mounting of medical devices |
US10092229B2 (en) | 2010-06-29 | 2018-10-09 | Abbott Diabetes Care Inc. | Calibration of analyte measurement system |
US20130211219A1 (en) * | 2010-08-24 | 2013-08-15 | Micro CHIPS ,Inc. | Implantable Biosensor Device and Methods of Use Thereof |
EP2624745A4 (en) | 2010-10-07 | 2018-05-23 | Abbott Diabetes Care, Inc. | Analyte monitoring devices and methods |
US8795230B2 (en) | 2010-11-30 | 2014-08-05 | Becton, Dickinson And Company | Adjustable height needle infusion device |
US8814831B2 (en) | 2010-11-30 | 2014-08-26 | Becton, Dickinson And Company | Ballistic microneedle infusion device |
US9950109B2 (en) | 2010-11-30 | 2018-04-24 | Becton, Dickinson And Company | Slide-activated angled inserter and cantilevered ballistic insertion for intradermal drug infusion |
CA3177983A1 (en) | 2011-02-28 | 2012-11-15 | Abbott Diabetes Care Inc. | Devices, systems, and methods associated with analyte monitoring devices and devices incorporating the same |
US10136845B2 (en) | 2011-02-28 | 2018-11-27 | Abbott Diabetes Care Inc. | Devices, systems, and methods associated with analyte monitoring devices and devices incorporating the same |
EP2532305B1 (en) * | 2011-06-09 | 2014-08-13 | Dexcom, Inc. | Transcutaneous analyte sensor |
WO2013066873A1 (en) | 2011-10-31 | 2013-05-10 | Abbott Diabetes Care Inc. | Electronic devices having integrated reset systems and methods thereof |
US9622691B2 (en) | 2011-10-31 | 2017-04-18 | Abbott Diabetes Care Inc. | Model based variable risk false glucose threshold alarm prevention mechanism |
JP6443802B2 (en) | 2011-11-07 | 2018-12-26 | アボット ダイアベティス ケア インコーポレイテッドAbbott Diabetes Care Inc. | Analyte monitoring apparatus and method |
US8710993B2 (en) | 2011-11-23 | 2014-04-29 | Abbott Diabetes Care Inc. | Mitigating single point failure of devices in an analyte monitoring system and methods thereof |
US9317656B2 (en) | 2011-11-23 | 2016-04-19 | Abbott Diabetes Care Inc. | Compatibility mechanisms for devices in a continuous analyte monitoring system and methods thereof |
WO2013078426A2 (en) | 2011-11-25 | 2013-05-30 | Abbott Diabetes Care Inc. | Analyte monitoring system and methods of use |
FI3831283T3 (en) | 2011-12-11 | 2023-06-01 | Abbott Diabetes Care Inc | Analyte sensor devices, connections, and methods |
US9615779B2 (en) * | 2012-04-04 | 2017-04-11 | Dexcom, Inc. | Transcutaneous analyte sensors, applicators therefor, and associated methods |
US9180242B2 (en) | 2012-05-17 | 2015-11-10 | Tandem Diabetes Care, Inc. | Methods and devices for multiple fluid transfer |
US9201038B2 (en) * | 2012-07-24 | 2015-12-01 | Lifescan Scotland Limited | System and methods to account for interferents in a glucose biosensor |
EP3395252A1 (en) | 2012-08-30 | 2018-10-31 | Abbott Diabetes Care, Inc. | Dropout detection in continuous analyte monitoring data during data excursions |
US9968306B2 (en) | 2012-09-17 | 2018-05-15 | Abbott Diabetes Care Inc. | Methods and apparatuses for providing adverse condition notification with enhanced wireless communication range in analyte monitoring systems |
EP2901153A4 (en) | 2012-09-26 | 2016-04-27 | Abbott Diabetes Care Inc | Method and apparatus for improving lag correction during in vivo measurement of analyte concentration with analyte concentration variability and range data |
US20140213866A1 (en) | 2012-10-12 | 2014-07-31 | Dexcom, Inc. | Sensors for continuous analyte monitoring, and related methods |
US10466247B2 (en) | 2012-11-20 | 2019-11-05 | Becton, Dickinson And Company | System and method for diagnosing sensor performance using analyte-independent ratiometric signals |
US10327685B2 (en) | 2012-12-20 | 2019-06-25 | Becton, Dickinson And Company | System and method for using multiple sensor calibration methods |
US10820860B2 (en) * | 2013-03-14 | 2020-11-03 | One Drop Biosensor Technologies, Llc | On-body microsensor for biomonitoring |
US9182368B2 (en) * | 2013-03-14 | 2015-11-10 | Sano Intelligence, Inc. | Method of manufacturing a sensor for sensing analytes |
US9173998B2 (en) | 2013-03-14 | 2015-11-03 | Tandem Diabetes Care, Inc. | System and method for detecting occlusions in an infusion pump |
US10433773B1 (en) | 2013-03-15 | 2019-10-08 | Abbott Diabetes Care Inc. | Noise rejection methods and apparatus for sparsely sampled analyte sensor data |
US9474475B1 (en) | 2013-03-15 | 2016-10-25 | Abbott Diabetes Care Inc. | Multi-rate analyte sensor data collection with sample rate configurable signal processing |
US10076285B2 (en) | 2013-03-15 | 2018-09-18 | Abbott Diabetes Care Inc. | Sensor fault detection using analyte sensor data pattern comparison |
US10379125B2 (en) | 2013-12-27 | 2019-08-13 | Becton, Dickinson And Company | System and method for dynamically calibrating and measuring analyte concentration in diabetes management monitors |
WO2015102745A1 (en) | 2013-12-31 | 2015-07-09 | Abbott Diabetes Care Inc. | Self-powered analyte sensor and devices using the same |
US10595754B2 (en) | 2014-03-13 | 2020-03-24 | Sano Intelligence, Inc. | System for monitoring body chemistry |
CN106102578A (en) | 2014-03-13 | 2016-11-09 | 萨诺智能公司 | For monitoring the system of body chemistry |
US20170185748A1 (en) | 2014-03-30 | 2017-06-29 | Abbott Diabetes Care Inc. | Method and Apparatus for Determining Meal Start and Peak Events in Analyte Monitoring Systems |
US20150289788A1 (en) | 2014-04-10 | 2015-10-15 | Dexcom, Inc. | Sensors for continuous analyte monitoring, and related methods |
US10004845B2 (en) | 2014-04-18 | 2018-06-26 | Becton, Dickinson And Company | Split piston metering pump |
US9416775B2 (en) | 2014-07-02 | 2016-08-16 | Becton, Dickinson And Company | Internal cam metering pump |
CN105873514B (en) * | 2014-10-27 | 2018-10-26 | 深圳市光聚通讯技术开发有限公司 | Dynamic glucose harvester and host |
KR20160115650A (en) * | 2015-03-25 | 2016-10-06 | 삼성전자주식회사 | Wearable electronic device |
WO2016153313A1 (en) * | 2015-03-25 | 2016-09-29 | Samsung Electronics Co., Ltd. | Wearable electronic device |
US10213139B2 (en) | 2015-05-14 | 2019-02-26 | Abbott Diabetes Care Inc. | Systems, devices, and methods for assembling an applicator and sensor control device |
AU2016260547B2 (en) | 2015-05-14 | 2020-09-03 | Abbott Diabetes Care Inc. | Compact medical device inserters and related systems and methods |
AU2016291569B2 (en) | 2015-07-10 | 2021-07-08 | Abbott Diabetes Care Inc. | System, device and method of dynamic glucose profile response to physiological parameters |
US10595900B2 (en) | 2015-10-21 | 2020-03-24 | Dexcom, Inc. | Transcutaneous analyte sensors, applicators therefor, and associated methods |
US20170188911A1 (en) | 2015-12-30 | 2017-07-06 | Dexcom, Inc. | Transcutaneous analyte sensor systems and methods |
US11071478B2 (en) | 2017-01-23 | 2021-07-27 | Abbott Diabetes Care Inc. | Systems, devices and methods for analyte sensor insertion |
WO2018175489A1 (en) | 2017-03-21 | 2018-09-27 | Abbott Diabetes Care Inc. | Methods, devices and system for providing diabetic condition diagnosis and therapy |
US20190120785A1 (en) | 2017-10-24 | 2019-04-25 | Dexcom, Inc. | Pre-connected analyte sensors |
US11331022B2 (en) | 2017-10-24 | 2022-05-17 | Dexcom, Inc. | Pre-connected analyte sensors |
US11464908B2 (en) | 2019-02-18 | 2022-10-11 | Tandem Diabetes Care, Inc. | Methods and apparatus for monitoring infusion sites for ambulatory infusion pumps |
CN110146553B (en) * | 2019-06-05 | 2022-02-08 | 东莞市盛山电子科技有限公司 | Electronic digital display chlorine tester test calibration method and tester thereof |
USD1002852S1 (en) | 2019-06-06 | 2023-10-24 | Abbott Diabetes Care Inc. | Analyte sensor device |
US20210032671A1 (en) * | 2019-08-02 | 2021-02-04 | Bionime Corporation | Method for Reducing Measurement Interference of Micro Biosensor |
USD999913S1 (en) | 2020-12-21 | 2023-09-26 | Abbott Diabetes Care Inc | Analyte sensor inserter |
USD988882S1 (en) | 2021-04-21 | 2023-06-13 | Informed Data Systems Inc. | Sensor assembly |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1996014026A1 (en) | 1994-11-04 | 1996-05-17 | Elan Medical Technologies Limited | Analyte-controlled liquid delivery device and analyte monitor |
Family Cites Families (53)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2408323A (en) | 1943-06-10 | 1946-09-24 | Margaret L Lockhart | Hypodermic syringe |
US2576951A (en) | 1950-09-29 | 1951-12-04 | Compule Corp | Hypodermic syringe assemblies, including plural-compartment admixing ampoules for segregated storage of ingredients of liquid mediginal solutions and parts thereof |
US3964482A (en) | 1971-05-17 | 1976-06-22 | Alza Corporation | Drug delivery device |
US4340458A (en) | 1980-06-02 | 1982-07-20 | Joslin Diabetes Center, Inc. | Glucose sensor |
US4515584A (en) | 1982-07-06 | 1985-05-07 | Fujisawa Pharmaceutical Co., Ltd. | Artificial pancreas |
EP0098592A3 (en) | 1982-07-06 | 1985-08-21 | Fujisawa Pharmaceutical Co., Ltd. | Portable artificial pancreas |
US4697622A (en) | 1984-06-01 | 1987-10-06 | Parker Hannifin Corporation | Passive filling device |
US4684365A (en) | 1985-01-24 | 1987-08-04 | Eaton Corporation | Disposable refill unit for implanted medication infusion device |
US4627445A (en) | 1985-04-08 | 1986-12-09 | Garid, Inc. | Glucose medical monitoring system |
US4684367A (en) | 1985-04-12 | 1987-08-04 | Meditec Research Associates | Ambulatory intravenous delivery system |
US4687423A (en) | 1985-06-07 | 1987-08-18 | Ivac Corporation | Electrochemically-driven pulsatile drug dispenser |
US4805624A (en) * | 1985-09-09 | 1989-02-21 | The Montefiore Hospital Association Of Western Pa | Low-potential electrochemical redox sensors |
GB8612861D0 (en) | 1986-05-27 | 1986-07-02 | Cambridge Life Sciences | Immobilised enzyme biosensors |
CA1283827C (en) | 1986-12-18 | 1991-05-07 | Giorgio Cirelli | Appliance for injection of liquid formulations |
US4902278A (en) | 1987-02-18 | 1990-02-20 | Ivac Corporation | Fluid delivery micropump |
DE3806955A1 (en) | 1987-03-03 | 1988-09-15 | Res Ass Bio Tech Chem | Glucose-sensitive FET sensor, and method for its fabrication |
GB8710472D0 (en) | 1987-05-01 | 1987-06-03 | Cambridge Life Sciences | Amperometric method |
GB8724446D0 (en) | 1987-10-19 | 1987-11-25 | Cambridge Life Sciences | Immobilised enzyme electrodes |
US5547467A (en) | 1988-01-21 | 1996-08-20 | Massachusettes Institute Of Technology | Method for rapid temporal control of molecular transport across tissue |
US5070886A (en) | 1988-01-22 | 1991-12-10 | Safety Diagnostice, Inc. | Blood collection and testing means |
GB8817997D0 (en) | 1988-07-28 | 1988-09-01 | Cambridge Life Sciences | Enzyme electrodes & improvements in manufacture thereof |
AT393213B (en) | 1989-02-08 | 1991-09-10 | Avl Verbrennungskraft Messtech | DEVICE FOR DETERMINING AT LEAST ONE MEDICAL MEASURING SIZE |
US4953552A (en) | 1989-04-21 | 1990-09-04 | Demarzo Arthur P | Blood glucose monitoring system |
EP0396788A1 (en) * | 1989-05-08 | 1990-11-14 | Dräger Nederland B.V. | Process and sensor for measuring the glucose content of glucosecontaining fluids |
US5298022A (en) | 1989-05-29 | 1994-03-29 | Amplifon Spa | Wearable artificial pancreas |
IT1231916B (en) | 1989-05-29 | 1992-01-15 | Ampliscientifica S R L | WEARABLE ARTIFICIAL PANCREAS |
CA2028261C (en) * | 1989-10-28 | 1995-01-17 | Won Suck Yang | Non-invasive method and apparatus for measuring blood glucose concentration |
US5286362A (en) | 1990-02-03 | 1994-02-15 | Boehringer Mannheim Gmbh | Method and sensor electrode system for the electrochemical determination of an analyte or an oxidoreductase as well as the use of suitable compounds therefor |
US5146091A (en) | 1990-04-19 | 1992-09-08 | Inomet, Inc. | Body fluid constituent measurement utilizing an interference pattern |
US5165407A (en) | 1990-04-19 | 1992-11-24 | The University Of Kansas | Implantable glucose sensor |
US5090963A (en) | 1990-10-19 | 1992-02-25 | Product Development (Z.G.S.) Ltd. | Electrochemically driven metering medicament dispenser |
US5242406A (en) | 1990-10-19 | 1993-09-07 | Sil Medics Ltd. | Liquid delivery device particularly useful for delivering drugs |
US5527288A (en) | 1990-12-13 | 1996-06-18 | Elan Medical Technologies Limited | Intradermal drug delivery device and method for intradermal delivery of drugs |
NL9002764A (en) | 1990-12-14 | 1992-07-01 | Tno | ELECTRODE, FITTED WITH A POLYMER COATING WITH A REDOX ENZYM BOND TO IT. |
US5562613A (en) | 1991-07-02 | 1996-10-08 | Intermed, Inc. | Subcutaneous drug delivery device |
US5322063A (en) | 1991-10-04 | 1994-06-21 | Eli Lilly And Company | Hydrophilic polyurethane membranes for electrochemical glucose sensors |
US5524338A (en) | 1991-10-22 | 1996-06-11 | Pi Medical Corporation | Method of making implantable microelectrode |
DE4139122C1 (en) | 1991-11-28 | 1993-04-08 | Fenzlein, Paul-Gerhard, 8500 Nuernberg, De | |
DE4221848C2 (en) * | 1992-07-03 | 2001-04-12 | Eckhard Salzsieder | Method and arrangement for automatic in situ calibration of intracorporeal glucose measuring devices |
GB9215973D0 (en) | 1992-07-28 | 1992-09-09 | Univ Manchester | Sensor devices |
IL102930A (en) | 1992-08-25 | 1997-03-18 | Yissum Res Dev Co | Electrobiochemical analytical method and electrodes |
US5330634A (en) * | 1992-08-28 | 1994-07-19 | Via Medical Corporation | Calibration solutions useful for analyses of biological fluids and methods employing same |
DK148592D0 (en) * | 1992-12-10 | 1992-12-10 | Novo Nordisk As | APPARATUS |
KR960004971B1 (en) | 1993-01-15 | 1996-04-18 | 경북대학교센서기술연구소 | Biosensor with ion-sensitive field-effect transistor |
US5545143A (en) | 1993-01-21 | 1996-08-13 | T. S. I. Medical | Device for subcutaneous medication delivery |
US5399245A (en) | 1993-09-03 | 1995-03-21 | North Carolina State University | Methods of indirect electrochemistry using ionomer coated electrodes |
US5582184A (en) | 1993-10-13 | 1996-12-10 | Integ Incorporated | Interstitial fluid collection and constituent measurement |
US5497772A (en) | 1993-11-19 | 1996-03-12 | Alfred E. Mann Foundation For Scientific Research | Glucose monitoring system |
JP3332561B2 (en) | 1994-03-17 | 2002-10-07 | イハラケミカル工業株式会社 | Method for producing thioaryl compound |
US5569186A (en) | 1994-04-25 | 1996-10-29 | Minimed Inc. | Closed loop infusion pump system with removable glucose sensor |
US5484059A (en) | 1994-08-18 | 1996-01-16 | Riverwood International Corporation | Carrier with bottom panel lock |
US5697366A (en) * | 1995-01-27 | 1997-12-16 | Optical Sensors Incorporated | In situ calibration system for sensors located in a physiologic line |
US5586553A (en) | 1995-02-16 | 1996-12-24 | Minimed Inc. | Transcutaneous sensor insertion set |
-
1998
- 1998-06-11 JP JP50406499A patent/JP2002505008A/en active Pending
- 1998-06-11 CA CA002294610A patent/CA2294610A1/en not_active Abandoned
- 1998-06-11 EP EP98928503A patent/EP0990151A2/en not_active Withdrawn
- 1998-06-11 AU AU80318/98A patent/AU8031898A/en not_active Abandoned
- 1998-06-11 WO PCT/IE1998/000045 patent/WO1998058250A2/en not_active Application Discontinuation
- 1998-06-16 TW TW087109549A patent/TW380046B/en not_active IP Right Cessation
- 1998-06-23 US US09/102,840 patent/US6275717B1/en not_active Expired - Lifetime
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1996014026A1 (en) | 1994-11-04 | 1996-05-17 | Elan Medical Technologies Limited | Analyte-controlled liquid delivery device and analyte monitor |
Cited By (110)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9662049B2 (en) | 1998-09-30 | 2017-05-30 | North Carolina State University | Methods and systems for monitoring patients undergoing treatment for cancer |
US7563350B2 (en) * | 1998-10-08 | 2009-07-21 | Abbott Diabetes Care Inc. | Small volume in vitro analyte sensor |
US9891185B2 (en) | 1998-10-08 | 2018-02-13 | Abbott Diabetes Care Inc. | Small volume in vitro analyte sensor |
WO2001013102A1 (en) * | 1999-08-11 | 2001-02-22 | Iit Limited | Sensor devices and analytical methods for their use |
WO2001021827A1 (en) * | 1999-09-20 | 2001-03-29 | Roche Diagnostics Corporation | Small volume biosensor for continuous analyte monitoring |
US7045054B1 (en) | 1999-09-20 | 2006-05-16 | Roche Diagnostics Corporation | Small volume biosensor for continuous analyte monitoring |
US7731835B2 (en) | 1999-09-20 | 2010-06-08 | Roche Diagnostics Operations, Inc. | Electrochemical sensor and method for continuous analyte monitoring |
WO2001022874A1 (en) * | 1999-09-29 | 2001-04-05 | Sicel Technologies, Inc. | Methods of calibrating in vivo sensor systems using in vivo generating electrodes and related devices |
WO2001033216A1 (en) * | 1999-11-04 | 2001-05-10 | Therasense, Inc. | Small volume in vitro analyte sensor and related methods |
US9662057B2 (en) | 2000-06-27 | 2017-05-30 | Abbott Diabetes Care Inc. | Integrated sample acquisition and analyte measurement method |
US6717154B2 (en) | 2000-08-02 | 2004-04-06 | Sicel Technologies, Inc. | Evaluation of irradiated foods and other items with telemetric dosimeters and associated methods |
US9797858B2 (en) | 2000-11-30 | 2017-10-24 | Panasonic Healthcare Holdings Co., Ltd. | Biosensor, measuring instrument for biosensor, and method of quantifying substrate |
US8101063B2 (en) | 2000-11-30 | 2012-01-24 | Panasonic Corporation | Method of measuring quantity of substrate |
US8298400B2 (en) | 2000-11-30 | 2012-10-30 | Panasonic Corporation | Method of measuring quantity of substrate |
US8097147B2 (en) | 2000-11-30 | 2012-01-17 | Panasonic Corporation | Method of measuring quantity of substrate |
US8668820B2 (en) * | 2000-11-30 | 2014-03-11 | Panasonic Corporation | Method of measuring quantity of substrate |
US10605757B2 (en) | 2000-11-30 | 2020-03-31 | Phc Holdings Corporation | Biosensor, measuring instrument for biosensor, and method of quantifying substrate |
WO2005065535A1 (en) * | 2003-12-30 | 2005-07-21 | Medtronic Minimed, Inc. | System and method for sensor recalibration |
US8777852B2 (en) | 2003-12-30 | 2014-07-15 | Medtronic Minimed, Inc. | System and method for sensor recalibration |
US7384397B2 (en) | 2003-12-30 | 2008-06-10 | Medtronic Minimed, Inc. | System and method for sensor recalibration |
US10067082B2 (en) | 2004-02-06 | 2018-09-04 | Ascensia Diabetes Care Holdings Ag | Biosensor for determining an analyte concentration |
US10327638B2 (en) | 2004-05-03 | 2019-06-25 | Dexcom, Inc. | Transcutaneous analyte sensor |
US9833143B2 (en) | 2004-05-03 | 2017-12-05 | Dexcom, Inc. | Transcutaneous analyte sensor |
US10827956B2 (en) | 2004-07-13 | 2020-11-10 | Dexcom, Inc. | Analyte sensor |
US10980452B2 (en) | 2004-07-13 | 2021-04-20 | Dexcom, Inc. | Analyte sensor |
US10813576B2 (en) | 2004-07-13 | 2020-10-27 | Dexcom, Inc. | Analyte sensor |
US10799159B2 (en) | 2004-07-13 | 2020-10-13 | Dexcom, Inc. | Analyte sensor |
US10918314B2 (en) | 2004-07-13 | 2021-02-16 | Dexcom, Inc. | Analyte sensor |
US10799158B2 (en) | 2004-07-13 | 2020-10-13 | Dexcom, Inc. | Analyte sensor |
US10918313B2 (en) | 2004-07-13 | 2021-02-16 | Dexcom, Inc. | Analyte sensor |
US10722152B2 (en) | 2004-07-13 | 2020-07-28 | Dexcom, Inc. | Analyte sensor |
US10932700B2 (en) | 2004-07-13 | 2021-03-02 | Dexcom, Inc. | Analyte sensor |
US10709362B2 (en) | 2004-07-13 | 2020-07-14 | Dexcom, Inc. | Analyte sensor |
US10709363B2 (en) | 2004-07-13 | 2020-07-14 | Dexcom, Inc. | Analyte sensor |
US9603557B2 (en) | 2004-07-13 | 2017-03-28 | Dexcom, Inc. | Transcutaneous analyte sensor |
US9610031B2 (en) | 2004-07-13 | 2017-04-04 | Dexcom, Inc. | Transcutaneous analyte sensor |
US10918315B2 (en) | 2004-07-13 | 2021-02-16 | Dexcom, Inc. | Analyte sensor |
US10524703B2 (en) | 2004-07-13 | 2020-01-07 | Dexcom, Inc. | Transcutaneous analyte sensor |
US10993641B2 (en) | 2004-07-13 | 2021-05-04 | Dexcom, Inc. | Analyte sensor |
US10993642B2 (en) | 2004-07-13 | 2021-05-04 | Dexcom, Inc. | Analyte sensor |
US11026605B1 (en) | 2004-07-13 | 2021-06-08 | Dexcom, Inc. | Analyte sensor |
US10314525B2 (en) | 2004-07-13 | 2019-06-11 | Dexcom, Inc. | Analyte sensor |
US11045120B2 (en) | 2004-07-13 | 2021-06-29 | Dexcom, Inc. | Analyte sensor |
US9775543B2 (en) | 2004-07-13 | 2017-10-03 | Dexcom, Inc. | Transcutaneous analyte sensor |
US11064917B2 (en) | 2004-07-13 | 2021-07-20 | Dexcom, Inc. | Analyte sensor |
US9801572B2 (en) | 2004-07-13 | 2017-10-31 | Dexcom, Inc. | Transcutaneous analyte sensor |
US9814414B2 (en) | 2004-07-13 | 2017-11-14 | Dexcom, Inc. | Transcutaneous analyte sensor |
US10022078B2 (en) | 2004-07-13 | 2018-07-17 | Dexcom, Inc. | Analyte sensor |
US11883164B2 (en) | 2004-07-13 | 2024-01-30 | Dexcom, Inc. | System and methods for processing analyte sensor data for sensor calibration |
US9833176B2 (en) | 2004-07-13 | 2017-12-05 | Dexcom, Inc. | Transcutaneous analyte sensor |
US9986942B2 (en) | 2004-07-13 | 2018-06-05 | Dexcom, Inc. | Analyte sensor |
US10743801B2 (en) | 2005-03-10 | 2020-08-18 | Dexcom, Inc. | System and methods for processing analyte sensor data for sensor calibration |
US10918317B2 (en) | 2005-03-10 | 2021-02-16 | Dexcom, Inc. | System and methods for processing analyte sensor data for sensor calibration |
US11051726B2 (en) | 2005-03-10 | 2021-07-06 | Dexcom, Inc. | System and methods for processing analyte sensor data for sensor calibration |
US11000213B2 (en) | 2005-03-10 | 2021-05-11 | Dexcom, Inc. | System and methods for processing analyte sensor data for sensor calibration |
US10925524B2 (en) | 2005-03-10 | 2021-02-23 | Dexcom, Inc. | System and methods for processing analyte sensor data for sensor calibration |
US10918318B2 (en) | 2005-03-10 | 2021-02-16 | Dexcom, Inc. | System and methods for processing analyte sensor data for sensor calibration |
US10918316B2 (en) | 2005-03-10 | 2021-02-16 | Dexcom, Inc. | System and methods for processing analyte sensor data for sensor calibration |
US10610137B2 (en) | 2005-03-10 | 2020-04-07 | Dexcom, Inc. | System and methods for processing analyte sensor data for sensor calibration |
US10898114B2 (en) | 2005-03-10 | 2021-01-26 | Dexcom, Inc. | System and methods for processing analyte sensor data for sensor calibration |
US10856787B2 (en) | 2005-03-10 | 2020-12-08 | Dexcom, Inc. | System and methods for processing analyte sensor data for sensor calibration |
US10610136B2 (en) | 2005-03-10 | 2020-04-07 | Dexcom, Inc. | System and methods for processing analyte sensor data for sensor calibration |
US10716498B2 (en) | 2005-03-10 | 2020-07-21 | Dexcom, Inc. | System and methods for processing analyte sensor data for sensor calibration |
US10709364B2 (en) | 2005-03-10 | 2020-07-14 | Dexcom, Inc. | System and methods for processing analyte sensor data for sensor calibration |
US10617336B2 (en) | 2005-03-10 | 2020-04-14 | Dexcom, Inc. | System and methods for processing analyte sensor data for sensor calibration |
US10610135B2 (en) | 2005-03-10 | 2020-04-07 | Dexcom, Inc. | System and methods for processing analyte sensor data for sensor calibration |
US10813577B2 (en) | 2005-06-21 | 2020-10-27 | Dexcom, Inc. | Analyte sensor |
AU2006272909B2 (en) * | 2005-07-20 | 2013-02-07 | Bayer Healthcare Llc | Gated amperometry |
TWI427289B (en) * | 2005-07-20 | 2014-02-21 | Bayer Healthcare Llc | Gated amperometry |
WO2007013915A1 (en) * | 2005-07-20 | 2007-02-01 | Bayer Healthcare Llc | Gated amperometry |
CN103558284B (en) * | 2005-07-20 | 2017-04-12 | 安晟信医疗科技控股公司 | Gated amperometry |
CN110376269A (en) * | 2005-07-20 | 2019-10-25 | 安晟信医疗科技控股公司 | The method for determining the input signal duration |
AU2016213744B2 (en) * | 2005-07-20 | 2017-11-23 | Ascensia Diabetes Care Holdings Ag | Gated amperometry |
JP2012247433A (en) * | 2005-07-20 | 2012-12-13 | Bayer Healthcare Llc | Gating current measuring instrument |
JP2009503452A (en) * | 2005-07-20 | 2009-01-29 | バイエル・ヘルスケア・エルエルシー | Gated current measuring instrument |
EP3483599A1 (en) * | 2005-07-20 | 2019-05-15 | Ascensia Diabetes Care Holdings AG | Methods for measuring the concentration of an analyte in solution and for calibrating the measurement as well as handheld devices therefor |
CN110376270A (en) * | 2005-07-20 | 2019-10-25 | 安晟信医疗科技控股公司 | The method for measuring sample temperature |
AU2014218413B2 (en) * | 2005-07-20 | 2016-09-15 | Ascensia Diabetes Care Holdings Ag | Gated amperometry |
CN106970135A (en) * | 2005-07-20 | 2017-07-21 | 安晟信医疗科技控股公司 | Gated amperometry |
CN106970135B (en) * | 2005-07-20 | 2019-09-06 | 安晟信医疗科技控股公司 | Gated amperometry |
AU2013200069B2 (en) * | 2005-07-20 | 2014-06-05 | Ascensia Diabetes Care Holdings Ag | Gated amperometry |
US9835582B2 (en) | 2005-09-30 | 2017-12-05 | Ascensia Diabetes Care Holdings Ag | Devices using gated voltammetry methods |
US11435312B2 (en) | 2005-09-30 | 2022-09-06 | Ascensia Diabetes Care Holdings Ag | Devices using gated voltammetry methods |
US10670553B2 (en) | 2005-09-30 | 2020-06-02 | Ascensia Diabetes Care Holdings Ag | Devices using gated voltammetry methods |
EP1860432A1 (en) * | 2006-05-24 | 2007-11-28 | Bionime GmbH | A method for operating a measuring meter and a measuring meter |
CN101078719B (en) * | 2006-05-24 | 2013-02-20 | 华广生技股份有限公司 | Method for operating measuring meter and measuring meter |
US8236165B2 (en) * | 2006-05-24 | 2012-08-07 | Bionime Corporation | Method for operating measuring meter and measuring meter |
US11091790B2 (en) | 2006-10-24 | 2021-08-17 | Ascensia Diabetes Care Holdings Ag | Determining analyte concentration from variant concentration distribution in measurable species |
US10190150B2 (en) | 2006-10-24 | 2019-01-29 | Ascensia Diabetes Care Holdings Ag | Determining analyte concentration from variant concentration distribution in measurable species |
US8721544B2 (en) | 2007-03-20 | 2014-05-13 | Roche Diagnostics Operations, Inc. | System for in-vivo measurement of an analyte concentration |
US9636049B2 (en) | 2007-03-20 | 2017-05-02 | Roche Diagnostics Operations, Inc. | Method of compression data from in-vivo measurements of an analyte concentration in a human |
EP2142096A4 (en) * | 2007-04-04 | 2010-12-29 | Isense Corp | Analyte sensing device having one or more sensing electrodes |
EP2142096A1 (en) * | 2007-04-04 | 2010-01-13 | Isense Corporation | Analyte sensing device having one or more sensing electrodes |
US9933385B2 (en) | 2007-12-10 | 2018-04-03 | Ascensia Diabetes Care Holdings Ag | Method of using an electrochemical test sensor |
CN107091870B (en) * | 2007-12-10 | 2019-10-08 | 安晟信医疗科技控股公司 | Determine measuring device, bio-sensor system and the method for analyte concentration |
US10690614B2 (en) | 2007-12-10 | 2020-06-23 | Ascensia Diabetes Care Holdings Ag | Method of using an electrochemical test sensor |
CN107091870A (en) * | 2007-12-10 | 2017-08-25 | 安晟信医疗科技控股公司 | Determine measurement apparatus, bio-sensor system and the method for analyte concentration |
US10739350B2 (en) | 2007-12-10 | 2020-08-11 | Ascensia Diabetes Care Holdings Ag | Method for determining analyte concentration based on slope-based compensation |
US20100327886A1 (en) * | 2008-03-27 | 2010-12-30 | Toshifumi Nakamura | Measurement device, measurement system, and concentration measurement method |
US10656113B2 (en) | 2008-12-08 | 2020-05-19 | Ascensia Diabetes Care Holdings Ag | Biosensor systems for determining analyte concentration based on complex index functions |
US8744776B2 (en) | 2008-12-08 | 2014-06-03 | Bayer Healthcare Llc | Method for determining analyte concentration based on complex index functions |
EP2408368A1 (en) * | 2009-03-16 | 2012-01-25 | Arkray, Inc. | Method of continuously measuring substrate concentration |
WO2010106781A1 (en) | 2009-03-16 | 2010-09-23 | Arkray, Inc. | Method of continuously measuring substrate concentration |
EP2408368A4 (en) * | 2009-03-16 | 2013-12-25 | Arkray Inc | Method of continuously measuring substrate concentration |
US10591436B2 (en) | 2010-03-22 | 2020-03-17 | Ascensia Diabetes Care Holdings Ag | Residual compensation including underfill error |
US9995702B2 (en) | 2010-06-07 | 2018-06-12 | Ascensia Diabetes Care Holdsings AG | Slope-base compensation including secondary output signals |
US10921278B2 (en) | 2010-06-07 | 2021-02-16 | Ascensia Diabetes Care Holdings Ag | Slope-based compensation including secondary output signals |
US9164076B2 (en) | 2010-06-07 | 2015-10-20 | Bayer Healthcare Llc | Slope-based compensation including secondary output signals |
US9775806B2 (en) | 2011-09-21 | 2017-10-03 | Ascensia Diabetes Care Holdings Ag | Analysis compensation including segmented signals |
US10646445B2 (en) | 2011-09-21 | 2020-05-12 | Ascensia Diabetes Care Holdings Ag | Analysis compensation including segmented signals converted into signal processing parameters for describing a portion of total error |
Also Published As
Publication number | Publication date |
---|---|
TW380046B (en) | 2000-01-21 |
WO1998058250A3 (en) | 1999-04-01 |
US6275717B1 (en) | 2001-08-14 |
AU8031898A (en) | 1999-01-04 |
JP2002505008A (en) | 2002-02-12 |
CA2294610A1 (en) | 1998-12-23 |
EP0990151A2 (en) | 2000-04-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6275717B1 (en) | Device and method of calibrating and testing a sensor for in vivo measurement of an analyte | |
AU713246B2 (en) | Methods of measuring the concentration of an analyte in a subject | |
CA2882514C (en) | Real-time self-calibrating sensor system and method | |
US6424847B1 (en) | Glucose monitor calibration methods | |
CA2930100C (en) | Methods and systems for detecting the hydration of sensors | |
EP2959829B1 (en) | Methods and systems for observing sensor parameters | |
JP5788874B2 (en) | Analyte monitoring device and method of use | |
JP5654586B2 (en) | Analyte monitoring device and method of use | |
JP5674777B2 (en) | Analyte monitoring device and method of use | |
US9255903B2 (en) | Methods of producing an electrochemical sensor for determining an analyte concentration | |
US4853091A (en) | Method and apparatus for the electrochemical determination of oxygen concentration | |
US20020042561A1 (en) | Implantable sensor and integrity tests therefor | |
US8594760B2 (en) | In vivo analyte monitor with malfunction detection | |
US20070151868A1 (en) | Implantable electrode system, method and apparatus for measuring an analyte concentration in a human or animal body | |
Fogt | Continuous ex vivo and in vivo monitoring with chemical sensors | |
KR20050093794A (en) | System and method for measuring coagulation time without thermostatic control | |
IE970443A1 (en) | Methods of calibrating and testing a sensor for in vivo¹measurement of an analyte and devices for use in such¹methods | |
EP0283962A2 (en) | Method for measuring periodontal pocket gases | |
Harsányi et al. | Low cost ceramic sensors for biomedical use: a revolution in transcutaneous blood oxygen monitoring? | |
CA3022118C (en) | Sensor device for detecting at least one analyte in a body fluid of a user |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AL AU CA CN HU IL JP KR LT LV MX NO NZ PL RO SG SI |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
ENP | Entry into the national phase |
Ref document number: 2294610 Country of ref document: CA Ref country code: CA Ref document number: 2294610 Kind code of ref document: A Format of ref document f/p: F |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1998928503 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 1998928503 Country of ref document: EP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1998928503 Country of ref document: EP |